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Abstract
In response to antigen presentation, helper T lymphocytes (TH cells) initiate store-operated
Ca2+ entry (SOCE) and differentiate into effector subtypes such as TH1 and TH2 cells. These
cells play essential roles in adaptive immunity and the pathogenesis of various autoimmune
and allergic diseases. The differentiation and activity of TH cells are also critically regulated
by paracrine and autocrine soluble factors in the cell microenvironment. Previous studies have
reported that TH cells produce gamma-aminobutyric acid (GABA) via glutamic acid
decarboxylase (GAD) and express A-type GABA receptors (GABAARs), forming an
autocrine GABA signaling system. In addition, GABA executes anti-inflammatory actions in
TH1-autoimmune diseases. This project sought to examine whether autocrine GABA signaling
distinctively regulates the function of different TH effector cells using two unique lines of
human TH cells: Jurkat and CCRF-CEM. Our results showed that Jurkat and CCRF-CEM cells
exhibited features of TH1 and TH2 phenotypes, respectively, and express different levels of
GABAAR subunits. Selective blockade of GABAARs differentially affected cell metabolic
activity, CRTh2 expression, NFAT expression, and store-operated Ca2+ entry (SOCE) in the
two cell lines. In conclusion, our results suggest that by modulating SOCE, autocrine GABA
signaling uniquely regulates the activity of different TH subtypes.
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Chapter 1: Introduction
1.1 Overview
CD4+ T lymphocytes, also known as T helper (TH) cells, play critical roles in the
adaptive immune system. They assist B lymphocytes (B cells) in the generation of antibodies,
regulate macrophage function, and produce cytokines to coordinate immune responses against
foreign microorganisms1. The differentiation of naïve TH cells into effector subtypes including
TH1, TH2 and TH17 cells is necessary for the generation of specific adaptive immune responses.
Dysregulation of this process could pave the way to a spectrum of autoimmune and
inflammatory disorders. For example, it has long been thought that an imbalance between
TH1 and TH2 cytokines contributes to the pathophysiology of asthma2,3. The differentiation
of TH cells is initiated during antigen presentation and critically modulated by microenvironmental cues4, which include soluble factors released through paracrine and autocrine
systems5–7. The exact mechanisms by which these factors regulate TH cell differentiation and
the functions of specific TH cell subtypes is not well understood.
An increasing pool of evidence indicates that gamma-aminobutyric acid (GABA), the
main inhibitory neurotransmitter in the central nervous system (CNS), also functions as a
signaling molecule in cells outside of the CNS8. GABA signaling proteins, including the
GABA-synthesis enzyme glutamic acid decarboxylase (GAD) and A-type GABA receptors
(GABAARs), are present in T cells and macrophages9, implying that these immune cells are
endowed with an autocrine GABAAR signaling system. Indeed, GABA has been shown to
play inhibitory roles in autoimmune and inflammatory diseases, which are largely TH1 cellmediated responses10. Recent studies in our lab have demonstrated that activation of
GABAARs in macrophages restrains M1 polarization while enhancing M2 polarization.
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Considering the analogous relationship between the TH1/TH2 and M1/M2 systems, we
proposed that GABAAR signaling may also differentially modulate different TH cell subtypes.
This thesis project sought to investigate if, and how, autocrine GABA signaling affects the
activities and functions of two unique human TH cell lines: Jurkat and CCRF-CEM.

1.2 Immune System
The human immune system is a complex host defense network consisting of multiple layers
of cellular and molecular components (illustrated in Figure 1.1). It plays a critical role in
protecting the body against infections and diseases caused by foreign microorganisms, toxins
and viruses. The immune system is generally classified into two main branches known as
innate and adaptive immunity, which are distinguished by their speed of response, specificity
against pathogens, and ability to generate immunological memory11. Despite these differences,
the innate and adaptive immune systems work in a synergistic manner to coordinate a broad
range of effects. Improper functioning of these systems can lead to immunological pathologies
such as autoimmunity, inflammatory diseases, and cancer12.

1.2.1 Innate Immunity
The innate immune system serves as the first line of defense by carrying out proinflammatory responses within seconds or minutes of an antigen’s presence in the body13. Its
primary function is to recruit immune cells to the source of infection through the production
of chemical messengers such as cytokines14. Other key functions include the clearance of dead
cells and activation of the adaptive immune response through antigen presentation13. Innate
immune cells recognize microbial pathogens through pattern-recognition receptors (PRRs) that
detect conserved pathogen-associated molecular patterns (PAMPs)15. Examples of PAMPs
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include components of microbial membranes, cell walls and DNA13. Important cellular
components of the innate immune system include tissue-specific macrophages, neutrophils,
natural killer cells, mast cells, and dendritic cells. Cells of the innate immune system, however,
cannot eliminate all infectious agents or recognize certain pathogens16. Thus, the adaptive
immune system has evolved to provide the body additional protection.

1.2.2 Adaptive Immunity
Adaptive immunity evolved much later than innate immunity and is only found in
cartilaginous fish and higher vertebrates17. In contrast to the innate immune system, the
adaptive immune system involves a more complicated process taking days to carry out
antigen-specific responses. The main functions of the adaptive immune system include the
recognition of specific “non-self” antigens in the presence of “self” antigens, the generation of
effector pathways that eliminate specific pathogens or infected cells, and the development
of immunological memory that can help eliminate a pathogen more efficiently during future
encounters18,19. The ability of this system to generate long-term immunological memory is the
basis of vaccination20. Cellular components of the adaptive immune system include naïve B
cells and T cells that may be differentiated to generate a wide range of adaptive immune
responses.
The adaptive immune system carries out two types of responses: humoral immunity,
involving antibodies produced by B cells, and cell-mediated immunity, carried out by T cells.
T cells and B cells originate from the bone marrow but undergo different developmental routes.
T cells, which are the focus of this thesis, mature in the thymus and recognize specific peptides
displayed by antigen-presenting cells (APCs). Cell-mediated immunity involves two main
types of T cells: TH cells and cytotoxic T cells, which are distinguished by the expression of
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cell surface glycoproteins CD4 and CD8, respectively. The main role of TH cells is to generate
chemical signals such as cytokines to direct other T cells, phagocytes and B cells during an
immune response18. Cytotoxic T cells, on the other hand, directly kill cells infected by viruses
and pathogens. The components of the adaptive immune system generate a more potent and
specialized response against specific microbial pathogens in comparison to the responses
carried out by the innate immune system. However, it must be emphasized that the adaptive
immune system cannot function without communication and activation from the innate
immune system. This is done through the formation of immunological synapses between APCs
of the innate immune system and T cells of the adaptive immune system21.
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Figure 1.1 Components of the innate and adaptive immune systems.
Reprinted from “Cytokines in cancer pathogenesis and cancer therapy,” by G Dranoff, 2004.
Nat Rev Cancer. 4: 11-22. Copyright (2004) by Nature Publishing Group. Reprinted with
permission.
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1.2.3 Antigen Presentation Process
Similar to how neurons communicate with each other at neuronal synapses, innate
immune cells can transmit signals to T cells at what are called immunological synapses19,22.
Here, resting T cells are activated by APCs displaying a major histocompatibility complex
(MHC). An MHC complex contains specialized molecules capable of presenting peptide
fragments to T cells at the T cell receptor (TCR). There are two major classes of MHCs, each
targeting a different type of T cell. The first kind are MHC class I molecules, which are found
ubiquitously in all healthy cells in the body and display peptide antigens within the cytoplasm
of cells. MHC I molecules report intracellular events such as viral infections and cellular
transformation to cytotoxic T cells23. In contrast, MHC class II molecules are restricted to
“professional” APCs such as macrophages, dendritic cells, and B cells. These molecules
display antigens from endocytic vesicles in cells; therefore, exogenous antigens are presented
to T cells on MHC II complexes. MHC II molecules target TH cells22,23. Effective activation of
TH cells also requires a secondary signal from APCs to ligate CD28, which is a co-receptor to
the TCR24. If proper co-stimulation is absent, TH cells go into a state of anergy where they
cannot respond to re-stimulation. Dendritic cells are the most important type of APCs due to
the expression of co-stimulatory molecules such as the B7 family of proteins, which are crucial
for proper T cell co-stimulation25,26.
When foreign pathogens are detected by APCs, they are ingested and degraded before
assembly and presentation on the cell surface as an MHC II. Only part of the foreign microbe,
such as the bacterial cell wall, is presented to T cells. Once TCRs are activated by MHC II
complexes, a signaling cascade resulting in Ca2+ influx is initiated16. While T cells require
activation from APCs, T cells can also regulate APC function through the release of specific
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cytokines. For example, macrophage polarization is regulated by cytokines released by effector
TH cells. This reflects the complementary relationship between innate and adaptive immunity.

1.2.4 G-Protein Coupled Receptors
In addition to activation mediated by antigenic TCR stimulation, T cells are also under
the influence of soluble factors in the microenvironment, which usually act upon G-protein
coupled receptors (GPCRs) spanning across the T cell membrane. T cells express various
types of GPCRs such as chemokine and muscarinic receptors28,29. While the roles of T cell
muscarinic receptors are still being investigated, chemokine receptors are well characterized
and are known to play important roles in T cell homeostasis28. Chemokines are soluble proteins
that regulate T cell migration and activation through GPCR-binding; these molecules are
differentially expressed in various TH cell subsets30. Binding of ligands to GPCRs activates the
G-protein α-subunit, which goes on to activate phospholipase C and induce Ca2+ entry
(explained in subsequent sections).

1.2.5 CRTh2 Receptor
Chemokine receptor homologous molecule expressed on T helper type 2 cells (CRTh2)
is a unique type of GPCR expressed in TH2 cells. It is activated by prostaglandin D2 (PGD2),
an arachidonic acid metabolite known to be released by activated mast cells and dendritic
cells31,32. Activation of CRTh2 has been shown to exacerbate asthmatic symptoms through
recruitment of eosinophils and TH2 cells, as well as the induction of TH2 cytokine synthesis33,34.
A selective CRTh2 agonist enhanced asthmatic symptoms in a mouse model of the disease35.
CRTh2 has also been suggested to be the most reliable marker of circulating TH2 cells36.
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Taken together, there is strong evidence that this receptor plays a critical role in regulating and
maintaining TH2 cell functions.

1.3 Store Operated Calcium Entry (SOCE)
Calcium ions (Ca2+) are an important secondary messenger in all eukaryotic cells. In
T cells, store-operated Ca2+ entry (SOCE) is the main signaling mechanism to increase
intracellular Ca2+ concentrations37. This type of Ca2+ signaling is dependent on the active
refilling of intraluminal Ca2+ in the endoplasmic reticulum (ER) by sarco-endoplasmic
reticulum Ca2+-ATPases (SERCAs)38. Once the ER Ca2+ stores are released, large amounts of
extracellular Ca2+ enter the cell to activate gene transcription. The elevation of intracellular
Ca2+ levels is crucial for triggering T cell activation by antigens and other stimuli such as
mitogens that cross-link the T cell receptor (TCR)39,40.

1.3.1 TCR Signaling Cascade
When TCRs are stimulated, a signaling cascade is initiated and eventually results in the
activation of Ca2+ release-activated Ca2+ (CRAC) channels (summarized in Figure 1.2). First,
the TCR activates phospholipase C (PLC), which hydrolyzes phosphatidylinositol 4,5bisphosphate (PIP2) into secondary messengers diacylglycerol (DAG) and 1,4,5-inositol
trisphosphate (IP3). IP3 opens Ca2+ channels on the endoplasmic reticulum (ER) to release Ca2+
into the cell cytosol, resulting in a drop in ER Ca2+ concentrations. This facilitates the rapid
influx of extracellular Ca2+ through CRAC channels41. Ca2+ entering the cytosol binds to the
regulatory protein calmodulin, which activates the phosphatase calcineurin. Calcineurin
dephosphorylates nuclear factor of activated T cells (NFAT) in the cytosol, which can then
translocate to the nucleus in its active, dephosphorylated form to modulate gene transcription18.
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In a parallel pathway, DAG, the other product of PIP2 hydrolysis, activates protein
kinase C (PKC), which activates the transcription factor nuclear factor κB (NF-κB), another
critical transcription factor in T cell activation42. The coordinated actions of various
transcription factors induce the expression of numerous genes important for the function of
activated T cells. The long-term functions of Ca2+ signaling also include cell proliferation,
effector functions such as the production of cytokines and chemokines, and the differentiation
of naïve T cells into various effector or memory T cells43. The amplitude, duration, and kinetics
of SOCE influence the specificity of gene activation events that help instruct T cells on which
differentiation pathway to take44.

1.3.2 CRAC Channels
CRAC channels are located on the T cell plasma membrane and are distinguished by
an extremely high selectivity for Ca2+ ions45. The exact composition and activation mechanism
of this channel were unknown until the discovery of its two protein components: Ca2+ sensor
protein stromal interaction molecule 1 (STIM1) and channel pore protein Orai146–49. STIM1
proteins are located on the ER membrane and are usually present as monomers containing Ca2+
ions in their Ca2+-binding sites near the protein’s N-terminal. Following a drop-in ER Ca2+
stores, Ca2+ falls off the protein and STIM1 monomers begin to form oligomers

50,51

.

Interaction between STIM1 oligomers and a cytosolic domain in Orai1 activates the CRAC
channel, allowing large amounts of extracellular Ca2+ into the T cell cytosol52.
It has been demonstrated that STIM1 proteins are crucial for CRAC channel function
and adaptive immunity; knockdown of STIM1 in mammalian cells and Drosophila S2 cells
results in suppressed CRAC channel conductance46,47. Homozygous nonsense mutations in the
STIM1 gene produce symptoms of severe immunodeficiency, autoimmune disease, and
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myopathy in human patients53. These symptoms are similar to those observed in patients with
Orai1 mutations, highlighting the critical role of CRAC channels and SOCE in immune
function and host defense54,55.

1.3.3 SOCE Regulation
The magnitude and rate of Ca2+ entry through CRAC channels is dependent on
endogenous regulators of CRAC channels as well as the membrane potential of cells44. For
example, several types of potassium (K+) channels can modulate the rate of Ca2+ entry by
hyperpolarizing the membrane, which increases the driving force for Ca2+ entry56,57. Studies
have demonstrated that K+-channel blockers could potentially be immunosuppressant58,59.
Therefore, modulators of T cell membrane potential could have significant effects on T cell
functions through their influence on SOCE. This concept is important in understanding the
results of this project.

1.3.4 Thapsigargin-induced SOCE
As mentioned previously, SOCE is a process mediated by active sequestration of
intracellular Ca2+ in endoplasmic reticulum stores by SERCAs38. Exogeneous compounds that
inhibit SERCAs are useful in the study of Ca2+ signaling mechanisms. Among these,
thapsigargin is the most widely used SERCA inhibitor due to its high potency and specificity.
This guaianolide compound is isolated from the Mediterranean plant Thapsia garganica L. It
works by counterbalancing the passive Ca2+ leak from ER stores in the cytosol. During in vitro
settings such as Ca2+ imaging and electrophysiology studies, thapsigargin can be applied to
induce an immediate but transient increase in cytosolic Ca2+ levels at concentrations in the
micromolar range60.
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Figure 1.2 Store-operated Calcium entry in T lymphocytes.
Reprinted from “Calcium signaling in lymphocyte activation and disease,” by S Feske. 2007.
Nat Rev Immunol. 7: 690-702. Copyright (2007) by Nature Publishing Group. Reprinted with
permission.
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1.4 T cell Development
T cell development is an intricate process occurring in the thymus; it involves the
maturation of lymphoid progenitor cells into mature CD4+ or CD8+ T cells that are then
released from the thymus to peripheral tissues61. Lymphoid progenitor cells originate from
haematopoietic stem cells in the bone marrow and enter the thymus through the circulation62.
Once they populate the thymus, progenitor cells lose the potential for B cell and natural killer
cell development and become committed to the T cell lineage63,64. These cells then expand by
cell division to generate a large population of immature thymocytes65–67. Thymocytes undergo
a series of developmental checkpoints to become mature T cells; this includes TCR β-chain
rearrangement followed by positive and negative selection68,69. These processes occur in
different areas of the thymus that have different microenvironments to support T cell
development. About 98% of thymocytes die during the development process in the thymus by
failing positive selection or negative selection70. This is to ensure that T cells function properly
in the peripheries. The thymus contributes fewer cells as a person ages, and eventually becomes
useless in older individuals where tissue expansion of immature T cells is the main source of
T cell generation71.
In general, the goal of T cell development is to produce T cells that have functional αβTCRs and can bind to self-antigens with a moderate affinity. Early progenitor cells lack the
expression of CD4 and CD8 and are termed double negative (DN) cells. DN thymocytes are
subdivided into four stages of differentiation identified by the expression of cell surface
markers CD44 and CD2572. DN1 cells (CD44+ CD25-) can give rise to several types of cells
including T cells, NK cells, dendritic cells, macrophages, and B cells. After specification to
the T cell lineage, DN2 cells (CD44+ CD25+) begin TCR gene arrangements. DN3 cells (CD44CD25+) have fully rearranged their TCR β-chain and associate with an invariant pre-TCR
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α-chain and CD3 signaling molecules to form the pre-TCR complex73. DN4 cells (CD44CD25-) upregulate expression of CD4 and CD8 to produce double-positive cells. The
progression through these stages is called the β-selection checkpoint. This process is crucial in
the generation of unique TCR sequences through gene rearrangement74,75. Following
β-selection, double positive (DP) cells undergo positive and negative selection76,77.
During positive selection, DP thymocytes are presented with self-antigens expressed
by thymic cortical epithelial cells on MHC I or MHC II molecules. Only thymocytes that
interact with MHC I or MHC II at moderate affinities will survive. This is to ensure that
selected T cells will have an MHC affinity that can serve useful functions in the body78.
Moreover, a thymocyte’s fate is determined by positive selection; DP cells that interact well
with MHC II molecules will eventually become CD4+ cells whereas those that interact with
MHC I molecules will become CD8+ cells79. Following positive selection, T cells undergo
negative selection where they bind to macrophages or dendritic cells expressing Class I or
Class II MHC containing “self” peptides. The goal of negative selection is the removal of
thymocytes that strongly bind with “self” MHC peptides. This prevents the formation of selfreactive T cells capable of causing autoimmune diseases80. After surviving positive and
negative selection, mature, singly positive T cells exit the thymus into peripheral systems
where they can be activated and further differentiated by APCs. The T cell developmental
process is summarized in Figure 1.3 –the locations of each developmental point in the thymus
are illustrated.
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Figure 1.3 T cell development in the thymus.
Reprinted from “T-cell development and the CD4-CD8 lineage decision,” by RN Germain.
2002. Nat Rev Immunol. 2: 309-322. Copyright (2007) by Nature Publishing Group. Reprinted
with permission.
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1.4.1 TH Cell Differentiation
During TCR activation in the presence of certain soluble factors in the immediate
environment, naïve CD4+ T cells may differentiate into one of several lineages of TH cells,
including TH1, TH2, TH17, and Treg, as defined by their pattern of cytokine production and
function81 (Figure 1.4). The exact factors and mechanism behind their differentiation in vivo
is still not well understood. However, previous literature have suggested that both the nature
of the presented antigen and the surrounding cytokine profile influence the differentiation of
naïve CD4+ T cells into specific subtypes1,82.

The initial steps of naïve CD4+ T cell

differentiation involve stimulation of the TCR and CD4 co-receptor with MHC II complexes
from APCs. The specific stimulatory conditions influence transcription factor expression,
which determines the differentiation route that the CD4+ T cell will follow.
The first two subtypes of TH cells were long recognized as the TH1 and TH2 cells. TH1
and TH2 development routes appear to be antagonistic, thus giving rise to a dichotomy
paradigm in TH cell differentiation83. However, several recent studies have shown more
complex patterns of cytokine interaction and the discovery of TH17 cells further suggests that
TH differentiation is not a simple dichotomy but rather, a spectrum1,81. During in vitro settings,
various cytokines can induce naïve TH cells to differentiate into a certain lineage84.
TH1 cells function to eliminate intracellular pathogens and play a role in organ-specific
autoimmunity and inflammation85. They produce IFN-γ as their signature cytokine and
produce IL-2 and TNF-α as well. IFN-γ is important for the activation of macrophages and
microglial cells, both mediators of phagocytic activity86. IL-2 promotes proliferation of CD8+
cytotoxic T cells and is also a growth factor for TH cells87. The master regulator for
differentiation of the TH1 cells is the T-box transcription factor (T-bet). Not only can it activate
sets of genes to promote TH1 differentiation, it can also suppress the development of opposing
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cell lineages88,89. Naïve TH cells could be induced to differentiate into TH1 cells by the addition
of IL-12 and IFN-γ in vitro90.
TH2 cells mediate immune responses to extracellular parasites and play a major role in
the pathophysiology of allergic disease85,91. They produce IL-4, IL-5, and IL-13 as their
signature cytokines. IL-4 is involved in antibody secretion by B cells and is important in
allergic inflammation92. IL-13 activates eosinophils, enhances mucus secretion and airway
hyperresponsivity in allergic asthma93. IL-5 is also involved in the activation of eosinophils94.
The master regulator involved in the differentiation of TH2 cells is GATA-binding protein
(GATA3)95. GATA3 enhances TH2 cytokine production, TH2 cell proliferation, and inhibits
TH1 differentiation through its interactions with T-bet96. Naïve TH cells could be induced to
differentiate into TH2 cells through the addition of IL-4 and IL-2 into the culture medium
in vitro.
The classic TH1/TH2 model of CD4+ TH cell has been significantly modified in recent
years with the addition of other types of CD4+ subsets. Among these is the TH17 subset that
was established as a true distinct CD4+ lineage in 2005 97. TH17 cells produce the cytokines
IL-17A, IL-17F and IL-22, and are thought to play a role in autoimmunity and inflammation.
Naïve TH cells could be induced to differentiate into TH17 cells by the addition of TGF-β and
IL-6 in vitro98. Another important TH subset are the Treg cells, which play a role in immune
tolerance and regulation of other TH subsets. They produce IL-10, IL-35, and TGF-β. Naïve
TH cells can be induced to differentiate into Treg by the addition of TGF-β and IL-2 in vitro99.
Given the time restrictions on this project, we chose to focus on the TH1 and TH2 cell
phenotypes. We acknowledge that TH differentiation involves many different subtypes and that
by only focusing on TH1 and TH2, we may be oversimplifying TH cell physiology. However,
considering that they are the two most well-established subtypes with clearly defined
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characteristics and roles in immune pathologies, this was a good place to start our
investigation. Moreover, the purpose of this project was to investigate GABA signaling
in two unique types of TH cell types. Future studies should involve the exploration of other
phenotypes of TH cells.

1.4.2 TH Cell Regulation of Macrophage Polarization
Although macrophages can direct TH cell differentiation through antigen presentation,
cytokines released from effector TH cells can also drive macrophage polarization towards proinflammatory (M1) and anti-inflammatory (M2) phenotypes100. M1 macrophages differentiate
under the influence of TH1 cytokine IFN-γ and bacterial lipopolysaccharide (LPS)101. These
macrophages are characterized by high microbicidal activity and the secretion of proinflammatory cytokines, reactive oxygen species (ROS), and iNOS. Conversely, M2
macrophages are differentiated under the influence of TH2 cytokines IL-4 and IL-13. This
phenotype is characterized by the selective expression of arginase-1 and mediate antiinflammatory responses102,103. The M1/M2 nomenclature was derived as an extension of the
TH1/TH2 system, reflecting their analogous relationship. It is important to note that macrophage
polarization is s very complex process and may not be a clear-cut dichotomy. Macrophages
can polarize into a continuum of pro-inflammatory and anti-inflammatory phenotypes.
Previous studies in our lab found that the expression levels of autocrine GABA
signaling proteins in macrophages are downregulated during M1 polarization and upregulated
during M2 polarization. Moreover, activation of GABAAR signaling in macrophages
restrained M1 activation but enhanced M2 responses. Considering the specific roles of TH1
and TH2 cells in the regulation of M1 and M2 polarization, it is possible that GABA also plays
different roles in TH1 and TH2 cells.
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Figure 1.4 Differentiation of naïve TH cells into various effector subtypes.
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1.4.3 Unique CD4+ Cell Lines
Many studies on T cell signaling mechanisms to date have been conducted using
transformed T cell lines. Among them, the best-known and most widely-used T cell model is
the Jurkat line, which was derived from human leukemic T cells104. Jurkat cells were first
established in 1977 from the peripheral blood of a 14-year-old boy and were crucial in the
discovery of the TCR activation pathway105. These cells express αβ-TCRs and the CD4
glycoprotein, a marker of TH cells. Upon stimulation with lectins or monoclonal antibodies
against the TCR, intracellular Ca2+ levels are increased and high levels of IL-2 are produced106.
Maximal production of IL-2 requires two synergistic signals: one from TCR activation and the
other by a phorbol ester such as phorbol myristate acetate (PMA)107.
Another unique T cell line is CCRF-CEM, which was established in 1964 from the
peripheral blood buffy coat of a 4-year-old girl108. These cells are not as well studied or
characterized as the Jurkat cells. However, they also express αβ-TCRs and CD4 exclusively.
Preliminary results from our collaborator Dr. Lisa Cameron’s lab in Department of Pathology
and Laboratory Medicine suggest that Jurkat and CCRF-CEM cells contain phenotypic traits
of TH1 and TH2 cells, respectively. When compared to each other, Jurkat cells contain
approximately double the amount of mRNA for IFN-γ, a classic TH1 cytokine, while CCRFCEM cells contain approximately five times the mRNA levels for IL-13, a classic TH2
cytokine. In addition, CCRF-CEM cells contain about six times the amount of mRNA for
CRTh2, a GPCR found in TH2 cells, and double the mRNA of GATA3, a TH2 transcription
factor. These results imply that Jurkat and CCRF-CEM cells contain certain features of TH1
and TH2 cells, respectively (Figure 1.5).
Although there are obvious limitations to using cell lines in research, they are often
used in place of primary cells because they also offer several advantages: they are cost
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effective, easy to use, easy to culture, and bypass certain ethical concerns. Cell lines also
provide a relatively pure population of cells, which is important since it provides consistent
samples and reproducible results109. Cultured T cell lines may be used in conjunction with
in vivo studies to provide a more thorough understanding of TH cell physiology.
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Figure 1.5 Comparison of mRNA levels of TH1 and TH2 markers in Jurkat and CCRFCEM cells.
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1.5 Gamma-Aminobutyric Acid
Gamma-aminobutyric acid (GABA) is widely known as the main inhibitory
neurotransmitter in the mammalian central nervous system (CNS). It works alongside the main
excitatory neurotransmitter glutamate to modulate inhibitory and excitatory balance for proper
brain functions110,111. GABA is involved in a variety of CNS responses and diseases involving
anxiety-related behavior, cognitive processing, and the discrimination of information112. For
example, changes in GABA signaling may contribute to the generation and spreading of
seizures in epilepsy113. Interestingly, it is becoming increasingly clear that the effects of GABA
on human physiology extend far beyond the CNS.
GABA is produced through the decarboxylation of glutamate by the enzyme glutamic
acid decarboxylase (GAD). In mammals, GAD exists in two isoforms: GAD65 and GAD67,
which are encoded by GAD1 and GAD2, respectively114. These two isoforms differ in
molecular weight (65 and 67 kDa), function, and localization. In neurons, GAD67 is spread
evenly throughout the cell body and synthesizes GABA for development and normal cell
function. GAD65 is generally localized to nerve terminals and is involved with GABA
synthesis for neurotransmission115.
GABA is degraded by the enzyme GABA transaminase (GABA-T) into succinate.
GABA-T inhibitors such as vigabatrin produce a significant increase in GABA in the brain
in vivo116. Another important component of the GABA signaling system are the GABA
transporters (GATs). These transporters remove GABA from the intercellular space after
synaptic transmission to prevent tonic activation of GABA receptors117. GABA acts on two
different types of receptors: ionotropic GABA-A receptors (GABAARs), which are chloride
channels, and metabotropic GABA-B receptors (GABABRs), which are GPCRs. Both types of
receptors are located in the plasma membrane of cells. In the adult brain, GABA mainly acts
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through activation of the fast hyperpolarizing GABAARs. When GABA binds to these
receptors, the ion channel opens and Cl- diffuses into the neuronal cell along its concentration
gradient118. On the other hand, GABABRs are responsible for the later and slower component
of inhibitory transmission119. Activation of these receptors initiates a GPCR-mediated pathway
that activates postsynaptic K+ channels or inhibition of presynaptic Ca2+ channels. In the brain,
approximately 20% of neurons are GABAergic and most of the physiological activities of
GABA are generated through GABAARs
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. The focus of this thesis is on GABA signaling

mediated through GABAARs.

1.5.1 GABAAR Structure
GABAARs are formed by the assembly of five heterogeneous subunits. Each subunit
contains four transmembrane regions, an extracellular N-terminal, and an intracellular
C-terminal. 19 different mammalian GABAAR subunits have been cloned (α1-6, β1-3, γ1-3, δ,
ε, π, θ, and ρ1-3) thus far121. However, most of the physiologically relevant receptor
compositions are formed by two α, two β, and one other subunit, most frequently the γ
subunit122 (Figure 1.6). Both the α and β GABAAR subunits are critical for GABAAR
activation123. The diversity of the subunit combinations is dictated by the GABAAR subunits
that assemble from their component subunits in the endoplasmic reticulum (ER). Subunits that
are not used are retained in the ER and degraded by ubiquitylation124,125. However, what
determines these unique subunit combinations is still a subject of investigation. The α1β2γ2containing GABAARs are the most abundant subtype of GABAAR in the brain126. The
molecular weights of individual GABAAR subunits range from 43-66 kDa and the estimated
molecular weight of the entire GABAAR complex is approximately 300 kDa.
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Figure 1.6 Illustration of a GABAAR formed from two α, two β, and one γ subunit.
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The GABAAR is a pentameric Cl- channel that opens upon the binding of GABA and
the selective agonist muscimol. The competitive antagonists bicuculline and SR-95531
compete for the GABA binding site to decrease GABAAR conductance. As Cl- channels,
GABAARs can mediate Cl- currents into or out of cells depending on the resting membrane
potential and the equilibrium potential for Cl-. The latter is governed by the expression and
activity of Cl- transporters in neuronal cells127.

1.5.2 Chloride Transporters
In mature neurons, activation of GABAARs generally results in hyperpolarization of
the cell and thus inhibition of neuronal activity128. This is because the equilibrium potential for
Cl- is below (more negative) the neuronal resting membrane potential so Cl- enters the cells
during GABAAR activation. However, GABA plays an excitatory role in immature neurons
because they contain higher intracellular Cl- levels, resulting in Cl- efflux and depolarization
of the cell upon GABAAR activation129. The intracellular Cl- of neurons is predominantly
regulated by two Cl- transporters, NKCC1 and KCC2. NKCC1 increases intracellular Cllevels by internalizing one Na+, one K+ and two Cl- ions to maintain electroneutral levels130.
Immature neurons express high levels of NKCC1 to maintain high intracellular Cl-. On the
other hand, KCC2 decreases intracellular Cl- levels by extruding K+ and Cl- using the
electrochemical gradient of K+. KCC2 is expressed at higher levels in mature neurons to
maintain low intracellular Cl- concentrations127. NKCC1 is expressed ubiquitously in the body
while KCC2 is only expressed in neurons. Therefore, the expression and activity levels of
NKCC and KCC transporters in different cell types control the intracellular Cl- concentrations
and determine the direction of Cl- currents.
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1.5.3 GABA Signaling Outside of the CNS
A majority of studies on GABA signaling to date have been in the context of the CNS.
However, components of the GABA signaling system have also been identified in several nonneuronal tissues including the pancreatic islets, testis and immune cells131–133. GABA appears
to play important regulatory roles in many cell types. In the pancreas, GABA originating from
β-cells can act on GABAARs on α-cells to cause membrane hyperpolarization and suppression
of glucagon secretion134,135. Recently, an autocrine GABA signaling system was found in
pancreatic β-cells and have been shown to promote β-cell regeneration136. GABA produces
membrane depolarization and activation of growth and survival pathways in β-cells. In animal
models of Type I Diabetes (T1D), GABA prevents and reverses the disease by enhancing
β-cell growth and survival136. Therefore, GABA can play opposing roles in the two main cell
types of the pancreas by hyperpolarizing α-cells while depolarizing β-cells.
GABA has also been demonstrated to play a role in testicular physiology by regulating
steroid synthesis by Leydig cells. GABA signaling proteins including GAD65/67, VGAT, and
GABAAR subunits were detected in rodent and human testis137. In a mouse cell line of Leydig
cells called TM3, GABA agonists increased the proliferation of the cells138. These data suggest
that an autocrine GABAergic system can play regulatory roles in many different endocrine cell
types. However, studies on GABAergic regulation of immune cells have only emerged in the
last decade or so.

1.5.4 GABA in the Immune System
APCs: Components of the GABA signaling system have been detected in APCs
including dendritic cells and macrophages139. GAD65 was detected in dendritic cells and
macrophages from encephalomyelitis (EAE) mice while GAD67 was found in human

27
peripheral monocytes140. GABA-T has also been detected in macrophages and human
monocytes139,141. In murine macrophages,

GABAAR α1, α2, β3 and δ subunits were

detected142. Human peripheral monocytes express the α1, α3, β2 and the δ subunits143. So far,
dendritic cells have not been reported to express GABAARs.
Anaesthetics that act through GABAARs severely compromise the immune system of
patients. Functional GABAARs are present in monocytes and inhibit normal monocyte
behaviour, which could contribute to the development of infections144. On the other hand, this
effect could be beneficial during inflammatory conditions. GABA has also been shown to
inhibit pro-inflammatory cytokine secretion in dendritic cells and macrophages from wildtype
and EAE mice 139,142.
As previously introduced, studies in our lab have shown that GABAAR signaling could
regulate macrophage polarization by promoting cells toward an M2 phenotype and inhibiting
M1 development. Moreover, when naïve macrophages were polarized towards the M1
phenotype, GABAARs were downregulated. The opposite was observed in macrophages
polarized towards the M2 phenotype, which had an upregulation of GABAARs145. This
suggests that the GABA signaling system plays critical roles in macrophage function and
polarization and that GABAAR expression is dependent on the phenotypic state of cells.
T cells: Many of the necessary components of the GABA signaling system have been
reported in T cells from different species. GAD and GABA-T have been identified in CD4+ T
cells from mice and in human T cells141,146. Mendu and colleagues conducted a comprehensive
study of mRNA expression of all 19 GABAAR subunits in human, mouse and rat CD4+ and
CD8+ T cells147. In rat T cells, α1, α2, α3, α4, α6, β2, β3, γ1, θ, π, ρ1, ρ2, and ρ3 subunits
were detected. In mouse T cells, α2, α3, α5, β2, β3, γ1, and δ subunits were detected. In human
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T cells, α1, α5, β1, π, and ρ2 subunits were detected. Lastly, in human Jurkat cells, α1, α3, α5,
α6, β1, β2, β3, π, and ρ1 subunits were detected147.
GABA has been shown to inhibit the activity of T cells from various species. GABA
and selective GABAAR agonist muscimol inhibited anti-CD3 mediated murine TH cell
proliferation in vitro; this effect was not seen with GABABR agonist baclofen, suggesting that
GABA’s effects are mediated through GABAARs148. GABA and muscimol were shown to
inhibit proliferation in human T cells as well141.
The various TH cell subsets exhibit different properties including cytokine production
patterns, regulatory mechanisms, and Ca2+ signaling kinetics149,150. Studies on the role of
GABA in T cells have generally been in the context of naïve TH cells or in autoimmune disease
models. Given that these are considered TH1-mediated responses, it would be interesting
to investigate whether GABA can play a different role in TH2 cells. TH1 and TH2 cell
development and functions are considered to oppose each other. GABA can play opposite
roles in mature and immature neurons, as well as in the pancreatic α and β cells. Whether
GABA differentially regulates TH cell subsets is largely unknown and our study aimed to add
insight into this topic.

1.5.5 GABA in Autoimmune Diseases
Numerous studies have provided evidence for an immunomodulatory role of GABA
in diseased states. A few of these will be highlighted in this section. It has been shown that
GABA inhibits pro-inflammatory CD4+ T cell responses and inhibit T cell autoimmunity in a
mouse model of Type 1 diabetes142,143,151,152. Oral GABA treatment downregulated
inflammatory responses in a mouse model of rheumatoid arthritis and in a mouse model of
obesity153. Dysregulation of GABA metabolism lead to autoimmunity in children who later
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had T1D154. Interestingly, pancreatic β cells widely express GAD65/67, which is targeted by
T cells during autoimmune destruction of β cells. In general, GABA appears to play a largely
inhibitory role in TH1-inflammatory and autoimmune disorders.

1.6 Rationale
CD4+ T cell differentiation is initiated by antigen presentation at the TCR and
influenced by cytokines in the cell microenvironment which act on GPCRs. On the other
hand, T cells have been shown to contain the necessary components of an autocrine GABAAR
signaling system. It is well known that the development and differentiation of many cell
types are under the influence of GABAARs. For example, autocrine GABAAR signaling
promotes neuro-progenitor cell differentiation155 and controls the phenotypic and functional
trans-differentiation of pancreatic α and β cells156. Studies in our lab have also demonstrated
that GABAAR activation inhibited M1 phenotype development while facilitating M2
development. M1 phenotype is driven by TH1 cytokines while M2 phenotype is driven by TH2
cytokines. Moreover, the M1/TH1 line of development drives autoimmune and inflammatory
responses. Therefore, this thesis sought to examine whether GABA can also play different
regulatory roles in TH cell phenotypes.
Another focus of this project was to investigate the underlying mechanism by which
GABAARs affect T cell functions. Given the importance of the membrane potential in driving
SOCE during T cell activation, we hypothesized that GABAARs mediate their effects by
changing the membrane potential of cells, hence modulating SOCE (illustrated in Figure 1.7).
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Figure 1.7 Proposed mechanism of GABAAR signaling in T lymphocytes.
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1.7 General Hypothesis
GABAAR-mediated autocrine signaling differentially regulates the activity and
functions of different TH cell types through indirect modulation of SOCE.

1.8 Objectives
This thesis sought to examine the role of GABAAR signaling in two TH cell lines to
establish proof of concept that GABA can play heterogeneous roles in different TH cell types.
Aim 1 – Characterize Jurkat and CCRF-CEM T Lymphocyte Lines
Since Jurkat and CCRF-CEM cells contain different profiles of transcription factors and
cytokines, the first aim was to further characterize the phenotypic and functional differences
between these two cell lines. Specifically, we examined cell proliferation rate, cell size, and
SOCE in response to thapsigargin stimulation.
Aim 2 –Examine the Expression of GABA Signaling Molecules
The composition of GABAARs varies between different species and even between different
cell types in an individual. Given the importance of subunit expression on receptor
pharmacological properties, we investigated which specific GABAAR subunits are expressed
in the two TH cell lines. We also examined whether stimulation of these cells could affect
GABAAR expression.
Aim 3 – Determine the Effects of GABAAR Agonists and Antagonists on Cell Function
GABA inhibits TH1 cell functions and TH1-mediated autoimmune diseases. To understand the
mechanism(s) by which it does this and whether GABA has the same effect on all TH subtypes,
we examined the effects of GABAAR agonist and antagonist on Ca2+ entry, nuclear NFAT
expression, metabolic activity, and cell surface protein expression in the two TH lines.
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Chapter 2: Materials and Methods

2.1 Cell Cultures
Jurkat cells (obtained from ATCC; Manassas, VA) were thawed in a 37 °C water bath
and transferred to a 100 mm culture dish containing 10 ml of RPMI-1640 medium
(ThermoFisher; Waltham, MA) supplemented with 10% fetal bovine serum (FBS;
ThermoFisher) and 100U/100 µg/mL penicillin/streptomycin (P/S; ThermoFisher). Cells
were grown in suspension and incubated at 37 °C with 95% O2 and 5% CO2. They were subcultured every three days by diluting in fresh culture medium at a 1:10 split ratio. Cells were
maintained at a density between 2 x 105 and 2 x 106 cells/mL as recommended by the supplier.
Jurkat cells used in this study were maintained from passages 1 through 30.
CCRF-CEM cells were obtained from Dr. Lisa Cameron’s lab at passage 2 and like
Jurkat cells, were cultured in 100 mm dishes containing 10 mL of RPMI-1640 (ThermoFisher)
medium supplemented with 10% FBS (ThermoFisher) and P/S (100U/100 µg/mL;
ThermoFisher). Cells were grown in suspension and incubated at 37 °C with 95% O2 and
5% CO2. They were sub-cultured every three days by diluting in fresh culture medium at a
1:10 split ratio. Cells were maintained at a density between 2 x 105 and 2 x 106 cells/mL.
CCRF-CEM cells used in this study were maintained from passages 1 through 30.

2.2 Cell Proliferation
The relative proliferative rates of the two cell lines were determined by counting and
plating 1 mL of cells (in triplicates) at an equal density (2 x 105 cells/mL) in a 12-well plate.
Cells were grown in regular culture medium (RPMI-1640 with 10% FBS and 100X P/S)
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over a period of 72 h. Live and dead cells were counted using trypan blue (1:1) (Sigma) on a
haemacytometer the day after plating (Day 1) as well as 72 h after plating (Day 3). The average
cell density for each cell line on each day were calculated from the triplicate wells.

2.3 MTT Assay
An MTT assay was used to test the effects of GABA and selective GABAAR antagonist
bicuculline on cell metabolic activity. A 96-well plate was coated with 10 µg/mL poly-D-lysine
(PDL; Sigma-Aldrich; Oakville, ON) at 37 °C overnight. The following day, the wells were
washed twice with PBS to remove unbound PDL. Jurkat and CCRF-CEM cells were counted
and 100 uL of cells were plated (5 x 105 cells/mL) and incubated for 30 min in serum-free
media to allow for attachment to the bottom of the wells. Following this period, the serumfree media was aspirated and cells were washed twice with PBS. Fresh RPMI-medium
(10% FBS) were added into the wells. Cells were left untreated (control) or treated with GABA
(100 µM; Sigma) or bicuculline (100 µM; Sigma) for 24 h at 37 °C.
Following the 24 h treatment period, 10 uL of MTT solution (5 mg/mL; Sigma) was
added into each well using a multi-channel pipet. The plate was incubated at 37 °C for 4 h.
Following incubation, the media was aspirated and 100 µL of DMSO was added into each well
and mixed thoroughly to break down the formazan crystals. The plate was read within 10 min
of DMSO addition using a Benchmark Microplate Reader (BioRad) at a wavelength of
570 nm. The experiment was conducted in quadruplet wells. Four wells containing only MTT
and DMSO were used to get a baseline reading; the average baseline reading was subtracted
from the readings from experimental wells. Values from each treatment were averaged among
the four replicates and normalized to control values (Control CCRF-CEM).
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2.4 Immunocytochemistry
Immunocytochemistry was used to determine the presence and localization of certain
proteins in fixed cells. Prior to staining, glass coverslips were placed in 12-well plates and
coated with 10 µg/mL PDL (Sigma-Aldrich) at 37 °C overnight. Coverslips were washed twice
with PBS the following day to remove unbound PDL. Cells were counted and plated at
5 x 105 cells per well for 30 min in serum-free media to allow for attachment to coverslips.
Following this period, the media was aspirated and cells were washed twice with PBS to
remove cells that did not attach to coverslips. Cells were fixed for 10 min in 4%
paraformaldehyde (PFA; Electron Microscopy Science; Hatfield, PA) solution diluted in PBS.
Cells were then washed once with PBS containing 0.1M glycine (Sigma-Aldrich) for
5 min, 2 x 5 min with PBS, and then incubated at 4 °C overnight.
The following day, fixed cells were permeabilized using 0.1% Triton X-100 (SigmaAldrich) in PBS for 5 min, washed with PBS for 5 min, and then blocked with 5% Normal
Donkey Serum (NDS; Jackson ImmunoResearch; West Grove, PA) diluted in PBS for 1 h to
prevent non-specific staining. Primary antibody (see Table 2.1 for list of primary antibodies)
diluted in 1% NDS was added to each coverslip and incubated overnight at 4 °C. The following
day, coverslips were washed with PBS for 3 x 5 min, followed by addition of secondary
antibody (see Table 2.1 for list of secondary antibodies) diluted in 5% NDS for 1 h at room
temperature to allow for conjugation to the primary antibody. Cells were then rinsed with PBS
and incubated with the nucleus stain 4', 6-diamidino-2-phenylindole (DAPI; 1 mg/ml; SigmaAldrich) for 10 min. Following immunostaining, coverslips were mounted on glass slides
(ThermoFisher) using Fluoromount GT (Electron Microscopy Sciences) and sealed with nail
polish to prevent coverslips from detachment.
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Cells were examined and imaged using the Olympus FV1000 microscope at the
Confocal Microscopy Core Facility located at Robarts Research Institute, London ON.
A 60X magnification was used for the experiments. The microscope settings were kept
consistent between and within experiments.

Table 2.1 Primary and secondary antibodies used for immunocytochemistry:
Primary Antibody

Source

Dilution

Company

STIM1

Rabbit

1:200

Proteintech Group Inc.

GABAAR-α1

Rabbit

1:100

Upstate

GAD65/67

Rabbit

1:1000

Sigma-Aldrich

NFATc2

Mouse

1:500

ThermoFisher

NKCC1

Goat

1:100

Santa Cruz

Secondary Antibody

Source

Dilution

Company

Cy3 anti-rabbit IgG

Donkey

1:600

Jackson Immunoresearch Labs

Cy3 anti-mouse IgG

Donkey

1:600

Jackson Immunoresearch Labs

Alexa 488 anti-mouse IgG

Donkey

1:600

Jackson Immunoresearch Labs

Alexa 488 anti-rabbit IgG

Donkey

1:600

Jackson Immunoresearch Labs
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2.5 Cell Size Analysis
Confocal imaging was also used to analyze the relative cell sizes of Jurkat and
CCRF-CEM cells. Ten differential interference contrast (DIC) images of each cell line were
analyzed using ImageJ software to obtain an average cell area for each cell type. The outline
of each cell was automatically determined as a region of interest (ROI) by the software and the
area within the ROI was calculated. Multiple images of cells in different groups were taken.
Approximately 30-50 cells were in the field of view of each image.

2.6 Mitogenic Stimulation of Cells
T cell activation is normally triggered by the antigenic stimulation of TCRs along with
a co-stimulatory signal to activate CD28. Stimulation of T cells with a mitogen such as
phytohaemagluttinin (PHA) and co-stimulus from phorbol 12-myristate 13-acetate (PMA) can
also induce cell activation and the production of cytokines (Sigma). PHA is a lectin that
crosslinks TCRs leading to receptor activation, while PMA is a phorbol ester that mimics DAG
and activates PKC.
For these experiments, a time course treatment was performed to examine the effects
of cell activation on the expression of various proteins over time. Cells were counted and
transferred to 15 mL tubes before centrifugation (1000 rpm, 4 °C, 5 min). The supernatants
were removed and cells were re-suspended in fresh growth medium. Cells were then plated in
60 mm dishes at a density of 5 x 105 cells/mL. Four dishes were plated for each cell line (one
each for control, 24 h, 48 h, 72 h treatments). Cells were treated with PHA-L (eBioscience) at
1 µg/mL and PMA (Sigma-Aldrich) at 50 ng/mL. Cells were re-harvested for whole cell lysate
collection at 24 h, 48 h, and 72 h after treatment.
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2.7 Western Blot
Whole cell lysate collection and Bradford assay
Western blot analysis was used to determine the relative amount of protein present in
cells at the time of whole cell lysate collection. Protein lysates of cells were collected using
SDS-free RIPA buffer (1.0% TritonX-100, 0.5% deoxychloric acid, and 1X phosphate buffer)
supplemented with 100 mM EDTA (pH 8.0), 10 µg/ml each of protease inhibitors Aprotinin
and Leupeptin (Sigma-Aldrich), and 2 mM of phenylmethylsulfonyl fluoride (PMSF; Sigma).
Samples were incubated on ice for 30 min prior to centrifugation at 13000 rpm for 5 min at
4 °C. The supernatants were collected and frozen at -80 °C for protein quantification and
Western blot analysis. The total protein concentrations of cell lysates were determined using a
Bradford assay. A protein standard from 0 to 25 µg/mL was prepared using bovine serum
albumin (BSA). The standard curve and protein concentrations were measured using a
spectrophotometer (Eppendorf Biophotometer Plus). The amount of protein loaded for gel
electrophoresis was optimized for each primary antibody (40-100 µg).

Gel electrophoresis
Prior to gel electrophoresis, whole cell lysates were mixed with 2X SDS loading buffer
containing 100 mM Tris HCl, 5% B-mercaptoethanol, 10% SDS, 20% Glycerol, and 0.1%
Bromophenol Blue. The samples were loaded on 4% stacking and 8% resolving
polyacrylamide gels and separated by gel electrophoresis. One lane was loaded with Pink Plus
Pre-stained Protein ladder (FroggaBio) to indicate the molecular weight of bands. A constant
voltage of 60 V was applied to samples to allow for migration through the stacking gel,
followed by an increase to 100 V for approximately 2 h through the resolving gel at room
temperature.
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Gel to membrane transfer and immunoblotting
Following gel electrophoresis, individual gels were wet-transferred to nitrocellulose
membranes (Bio-Rad) for 2 h at 80 V on ice using Tris-glycine transfer buffer (20 % methanol).
Following this transfer period, membranes were blocked with 5% w/v skim milk powder
diluted in TBS-T (10 mM Tris HCl pH 8.0, 150 mM NaCl and 0.1% Tween-20) for 1.5 h at
room temperature. Membranes were then incubated with primary antibody (see Table 2.2 for
primary antibodies) diluted in 5% w/v skim milk overnight at 4 °C. The following day,
membranes were washed with TBS-T (3 x 10 min) and incubated with secondary antibody (see
Table 2.2 for list of secondary antibodies) also diluted in 5% w/v skim milk for 1.5 h at room
temperature, followed by another set of TBS-T washes (3 x 10 min). Western ECL substrate
(BioRad) was used to detect the presence of secondary antibodies conjugated to HRP.

Imaging membranes
A VersaDoc Molecular Imager (Bio-Rad) was used to image the membranes. The
exposure times of individual membranes were optimized depending on the primary antibody
being detected. Several images of different exposure times were taken for each membrane.
Following imaging, the membranes were stripped using Restore Western Blot Stripping Buffer
(Thermo Scientific) for 10-15 min and blocked with 5% milk or 5% bovine serum albumin
(BSA) in TBS-T prior to the addition of β-actin or GAPDH primary antibodies, respectively.
These proteins were used as the loading controls for densitometry analysis of the bands.
Densitometry analysis was performed using ImageJ software and the protein of interest was
normalized to β-actin or GAPDH loading controls before further normalization to control
groups.
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Table 2.2 Primary and secondary antibodies used for Western Blot:
Primary Antibody

Source

Dilution

Company

Molecular
Weight

STIM1

Rabbit

1:800

Proteintech Group Inc.

80-90 kDa

Orai1

Rabbit

1:400

ABCAM

50 kDa

GAD65/67

Rabbit

1:1000

Sigma-Aldrich

65, 67 kDa

GABAAR-α1

Guinea Pig

1:1000

Alomone Labs

51 kDa

GABAAR- β1

Rabbit

1:1000

ABR

55 kDa

GABAAR- β3

Mouse

1:300

Santa Cruz

56 kDa

NKCC1

Goat

1:300

Santa Cruz

131 kDa

NFATc2

Mouse

1:1000

ThermoFisher

120 kDa

β-actin

Mouse

1:5000

Sigma-Aldrich

42 kDa

GAPDH

Mouse

1:1000

ABCAM

37 kDa

Secondary Antibody

Source

Dilution

Company

HRP-conjugated anti-guinea pig

Donkey

1:5000

Chemicon

HRP-conjugated anti-goat IgG

Rabbit

1:10000

BioRad Laboratories
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HRP-conjugated anti-rat IgG

Goat

1:5000

BioRad Laboratories

HRP-conjugated anti-rabbit IgG

Goat

1:10000

Jackson Immunoresearch

HRP-conjugated anti-mouse IgG

Sheep

1:10000

Amersham Bioscience

2.8 Calcium-Dependent Fluorescence Imaging
Cell Preparation
Calcium-dependent fluorescence imaging was used to examine the effects of GABAAR
agonists and antagonists on Ca2+ entry in the two cell lines. Prior to imaging, cells were
counted, centrifuged, and re-suspended in serum-free media before plating 1 mL at an equal
density (5 x105 cells/mL) in PDL-coated glass bottom dishes (MatTek Corporation; Ashland,
MA). Depending on the number of groups and trials being assessed, 6-8 dishes of cells were
prepared for each experiment. Cells were incubated for 30 min at 37 °C to allow for attachment
to the cover glass. Following attachment, cells were washed twice with extracellular solution
(ECS contents: 130 mM NaCl, 5.0 mM KCl, 2.0 mM MgCl2, 2.0 mM CaCl2, 10 mM HEPES,
5.0 mM Glucose) to remove unbound cells. Cells were then incubated with 1 µM Rhod-4AM
(AAT Bioquest; Sunnyvale, CA), a membrane-permeable Ca2+-dependent fluorescent
indicator, for 45 min at 37 °C to allow for Rhod-4AM to load into the cells. Following this
period, cells were gently rinsed with ECS three times and then brought to the imaging facility.

Rhod-4AM Fluorescence Imaging
Live cell imaging was performed using the Olympus FV1000 microscope at Robarts
Research Institute. The microscope was set up for detection of the Rhod-4AM fluorophore
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(excitation: 546 nm, emission: 560-620 nm) at 20X magnification. Once the dish was loaded
onto the microscope stage, a field of view (FOV) would be randomly selected for imaging.
Approximately 30-50 cells were in each FOV during these imaging experiments. The
microscope was set to run a time lapse where one image was captured every 2.7 s. When
imaging started, a baseline intensity of Rhod-4AM fluorescence was established by allowing
the microscope to run for 30 frames without addition of any test substances to the cell culture
dish. Following 30 images of baseline detection, specific test substances/drugs (1.0 µM
thapsigargin, 100 µM GABA and 100 µM bicuculline) were applied to the dish to examine
their effects on Rhod-4AM fluorescence in the cells. The working concentration of each test
substance was determined from examining the literature and from earlier optimization
experiments. The stock solution of thapsigargin was prepared using ethanol. The final working
concentration of ethanol was 0.05% and at this concentration, it had no vehicle effects on
Rhod-4AM florescence in the cells. GABA and bicuculline were both diluted in water.

Rhod-4AM Fluorescence Analysis
In this assay, intracellular Ca2+ levels were inferred from the fluorescence intensity of
Rhod-4AM. To analyze the relative levels of intracellular Ca2+, the time-lapse images were
uploaded into ImageJ software and converted to greyscale. The outlines of each cell were
automatically selected as regions of interest (ROIs) by the software. Cells that shifted locations
during the imaging time course were excluded from the analysis. The fluorescence intensity
of each image at each time point was detected by the software and normalized to baseline
fluorescence. The average Rhod-4AM fluorescence intensities calculated from individual cells
in each ROI were plotted against the time point. Lastly, the average fluorescence intensities
of Rhod-4AM were pooled from multiple trials of the same treatment group.
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2.9 Flow Cytometry
Flow cytometry was used to examine the effects of GABA and antagonist bicuculline
on cell surface expression of CRTh2. Cells were counted and plated at an equal volume and
density (3 mL at 2 x 105 cells/ mL) in a 6 well-plate and were either left untreated (control), or
treated with GABA (100 µM) or bicuculline (100 µM). The cells were incubated with the
treatments for 24 h at 37 °C before preparation for flow cytometry analysis.
Following the 24 h treatments, 5 x 106 cells from each condition were collected into
15 mL tubes. Cells were washed with PBS FACS (3% FBS, 0.5% BSA, 0.1% sodium azide)
and spun down at 900 RPM for 10 min at 4 °C. The cells were then re-suspended in fresh PBS
FACS and incubated with primary blocking antibody (rat IgG; BioLegend; San Diego, CA)
for 45 min at room temperature in the dark. Following the blocking step, anti-CRTh2
AlexaFluor 647 primary antibody (rat anti-human) or isotype control (both from BioLegend)
were added to the tubes and incubated for 30 min on ice. Cells were then washed and fixed
with 2% PFA prior to flow cytometry analysis. The experiments were conducted in duplicates.
Flow cytometry was performed at the London Regional Flow Cytometry Facility using the BD
LSR II Flow Cytometer and FloJo analysis software. The values of CRTh2 intensities were
normalized to control CCRF-CEM cells.

2.10 Statistical Analyses
Results from all experiments were presented as a mean ± SEM. To calculate statistical
differences between experimental groups, a Student’s T-test or two-way ANOVA followed by
a post-hoc Tukey’s test was used when appropriate. A P-value of less than 0.05 was considered
statistically significant. GraphPad Prism was used to generate all graphs and run statistical
analyses.
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Chapter 3: Results

3.1 Characterization of Jurkat and CCFR-CEM Lines
Preliminary results from qPCR assays performed by Dr. Cameron’s lab showed that
Jurkat and CCRF-CEM cells contained certain features of TH1 and TH2 effector cells,
respectively. To further characterize the differences between these two TH cell lines, we
examined basic phenotypic features including cell proliferation rate, cell size, expression levels
of CRAC channel proteins, and SOCE in response to thapsigargin. The following results
pertain to this first aim.

3.1.1 CCRF-CEM cells proliferate faster than Jurkat cells
We examined the relative rates at which each cell line proliferates by counting the
number of live cells in culture. More specifically, cells were plated at an equal density in
RPM1-1640 medium (10% FBS), and live cells were counted the day after plating (Day 1) and
3 days after plating (Day 3). On Day 1, the cell densities were almost identical between the
two cells lines, confirming that an equal number of cells were plated the day before
and that they have yet to divide.

On Day 3, the density of CCRF-CEM cells

(1.15 ± 0.0493 x 106 cells/mL) were significantly higher than that of Jurkat cells
(7.442 ± 0.729 x 105 cells/mL) (Figure 3.1). Almost all of cells (> 99%) were still viable
during the cell counts (data not shown). These results indicate that CCRF-CEM cells proliferate
at a relatively faster rate than Jurkat cells under culture conditions.
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Figure 3.1 Proliferation of Jurkat and CCRF-CEM cells under culture conditions.
Jurkat and CCRF-CEM cells were cultured in 12-well plates at an equal density
(2 x 105 cells/mL) in RPMI-1640 medium (10% FBS). Live cells were counted the day after
plating (Day 1) and 3 days after plating (Day 3) while apoptotic cells were identified using
trypan blue. Three wells per cell line were plated for the assay. The average densities of live
cells on Day 1 and Day 3 are plotted in the graph. The values from the triplicate wells were
analyzed using a two-way ANOVA followed by a post-hoc Tukey’s test. Data are reported as
a mean ± SEM (n=3 technical replicates) (** indicates P < 0.01).
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3.1.2 Jurkat cells are larger than CCRF-CEM cells
Another phenotypic trait that we examined were the relative cell sizes of the Jurkat and
CCRF-CEM lines. We assessed this by analyzing DIC images of both cell types using ImageJ
software. The average cell area obtained for Jurkat cells was 151 ± 6.83 µm2, which was
significantly larger than that of CCRF-CEM cells (107 ± 4.76 µm2) (Figure 3.2A). To confirm
the result from image analysis, we also assessed the cell size using flow cytometry, a technique
that can sort cells based on size and granularity. The forward scatter (x-axes) of a cell
population on a flow cytometric plot indicates its relative cell size. According to the flow plots,
the population of Jurkat cells on average had a larger forward scatter than CCRF-CEM cells,
providing further evidence that Jurkat cells are larger in size than CCRF-CEM cells
(Figure 3.2B).
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Figure 3.2

A

B
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Figure 3.2 Analysis of average cell size of Jurkat and CCRF-CEM cells.
A) Analysis of cell size by confocal microscopy in combination with image analysis.
Specifically, DIC images of both cell lines were taken with an Olympus confocal microscope
at 20X magnification under the same microscope settings. The confocal images were analyzed
using ImageJ software by converting into grayscale, outlining the outer membrane of each cell
and obtaining the area within each outlined region of interest. Representative images in the left
column are processed DIC images of Jurkat cells (upper panel) and CCRF-CEM cells (lower
panel). The graph at the right summarizes the average area of all cells from ten images taken
from each line. The average areas were analyzed using a two-way unpaired student’s T-test.
The data are reported as a mean ± SEM. (**** indicates P < 0.001). B) Assessment of average
cell size by flow cytometry. Shown are representative flow cytometry plots for each cell line.
The circled area in each plot represents the population of Jurkat and CCRF-CEM cells,
respectively. Forward scatter (x-axes) indicates relative cell size while side scatter (y-axes)
represents cell granularity.
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3.1.3 Both cell lines express CRAC channel components
Using Western blot, we examined whether Jurkat and CCRF-CEM cells express the
protein components of CRAC channels: ER Ca2+-sensor protein STIM1 and the channel
forming protein Orai1, both of which are required for SOCE mechanisms in TH cells. Western
blot analysis detected STIM1 as a single band at ~85 kDa while Orai1 was detected as a single
band at ~50 kDa in both cell lines (Figure 3.3). There were no observable differences in the
expression levels of STIM1 and Orai1 between the two cell lines. Nevertheless, these results
confirmed the expression of CRAC channel proteins by Jurkat and CCRF-CEM cells,
suggesting that they are capable of generating SOCE. Previous immunocytochemistry
experiments also detected STIM1 in Jurkat and RAW 264.7 cell co-cultures and in primary
murine splenocytes (Appendix Figure 6.1).
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Figure 3.3 Protein expression of STIM1 and Orai1 in Jurkat and CCRF-CEM cells.
Representative Western blot images of A) STIM1 and B) Orai1 from whole cell lysates of
Jurkat and CCRF-CEM cells. 50 µg and 100 µg of protein were loaded for the detection of
STIM1 and Orai1, respectively. GAPDH was used as a loading control. Note that the densities
of the STIM1 and Orai1 bands of Jurkat cells are similar to that of CCRF-CEM cells.
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3.1.4 Larger SOCE magnitude observed in Jurkat cells in response to thapsigargin
Thapsigargin is a compound commonly used to induce SOCE in cells under various
experimental settings. Since Jurkat and CCRF-CEM cells expressed relatively equal levels of
CRAC channel proteins (Figure 3.3), we wanted to examine whether their Ca2+ response to
thapsigargin would also be similar. It has been reported that different phenotypes of TH cells
contain unique Ca2+ signaling patterns, magnitude and rates 157,158.
Using Ca2+-based fluorescence imaging and a specific Ca2+ indicator Rhod-4AM,
indirect measurements of intracellular Ca2+ levels were recorded. Under control conditions
(without the addition of any test substances), Rhod-4AM intensity appeared to be higher in
Jurkat than in CCRF-CEM cells. There was also a greater variability in the intensity of
Rhod-4AM fluorescence among Jurkat cells within a dish compared to CCRF-CEM cells
(Figure 3.4A). Once 1 uM thapsigargin was applied to the cells, Rhod-4AM fluorescence
increased dramatically in both cell lines (Figure 3.4B). The changes in Rhod-4AM
fluorescence intensity over time were normalized to baseline fluorescence intensity to obtain
relative fold-changes in Rhod-4AM fluorescence within each dish. The peak fluorescence
levels were obtained from each trace and compared between the cell lines. The relative
intensity changes in Rhod-4AM following thapsigargin addition was significantly larger in
Jurkat cells (2.097 ± 0.04887, n=4) than in CCRF-CEM cells (1.759 ± 0.06665, n=4)
(P < 0.05). This suggests that Jurkat cells flux relatively larger amounts of Ca2+ once SOCE is
initiated by thapsigargin (Figure 3.4C).
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Figure 3.4

C
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Figure 3.4 Thapsigargin-induced Ca2+ influx in Jurkat and CCRF-CEM cells.
Ca2+-based fluorescence imaging was used to examine the effects of thapsigargin on
intracellular Ca2+ levels in Jurkat and CCRF-CEM cells. Cells were plated and loaded with
Rhod-4AM Ca2+ indicator prior to imaging. A) Representative images of a field of view for
Ca2+ imaging. The baseline Rhod-4AM fluorescence is shown on the left panels and the rise in
fluorescence following thapsigargin addition is shown in the right panels. B) Representative
traces of Rhod-4AM fluorescence, measured in arbitrary units of intensity (AUI), normalized
to baseline. The time point where thapsigargin was added into the dish is indicated by an arrow.
Each trace represents the average fluorescence intensity in a field of view containing 30-40
cells. C) The average peak Rhod-4AM fluorescence intensities for each cell line were
compared over several trials using an unpaired student’s T-test. Data are represented as a
mean ± SEM (n=4) (* indicates P < 0.05).
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3.2 Expression of GABA Signaling Proteins
To address the second aim, we examined the protein expression profiles of GABA
signaling proteins including GAD and various GABAAR subunits. A functional GABAAR
pentameric channel is composed of 2α, 2β, and one other subunit out of 19 possible types.
Considering the importance of α and β subunits for the formation of GABAARs and that Jurkat
cells express α1 and β1-3 subunits mRNA147, we decided to examine the α1, β1, and β3
subunits of GABAARs.

3.2.1 Glutamic acid decarboxylase is expressed in both cell lines
GABA is synthesized from glutamate by the enzyme glutamic acid decarboxylase
(GAD). This enzyme exists in two isoforms – GAD65 and GAD67, weighing 65 kDa and 67
kDa, respectively. Using a primary antibody that detects both isoforms, expression of GAD65
and GAD67 in Jurkat and CCRF-CEM cells were examined by Western blot. GAD was
detected as a double band at 65 kDa and 67 kDa in both cell lines (Fig 3.5A), while
immunocytochemistry detected the expression of GAD65/67 localized throughout the cell
cytoplasm. This indicates that both cell lines express GAD65/67, enabling them to produce
their own GABA.
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Figure 3.5 Protein expression and localization of glutamic acid decarboxylase (GAD) in
Jurkat and CCRF-CEM cells with rat cortex as a positive control.
Western blot and Immunocytochemistry were used to detect the expression and localization of
GAD65/67 in the two cell lines. A) Representative Western blot images of GAD65/67 and
GAPDH loading control in whole cell lysates of Jurkat and CCRF-CEM. 50 µg of protein was
loaded for GAD 65/67 detection. B) Representative immunofluorescence images of Jurkat and
CCRF-CEM cells stained with anti-GAD65/67 (Alexa 488, Green) and DAPI for nuclei (Blue).
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3.2.2 Various GABAAR subunits are expressed in both cell lines
Next, we examined whether Jurkat and CCRF-CEM cells express different GABAAR
subunits and whether the expression levels would differ between the cell lines. The first subunit
we looked at was GABAAR- α1, which is one of the most widely expressed subunits in the
mammalian brain159. Using immunocytochemistry, α1 was detected in both cell lines localized
throughout the cell cytosol and plasma membrane (Figure 3.6A).
After confirming the expression of α1 through immunocytochemistry, we used a more
quantitative technique to compare the expression levels of the α1 subunit between the two cell
lines. Our Western blot analysis detected α1 as a single band at approximately 51 kDa. After
normalizing these bands to GAPDH, it was determined that CCRF-CEM expressed
significantly higher levels of GABAAR-α1 compared to Jurkat cells (P < 0.01).
Two other GABAAR subunits were examined in this study, GABAAR-β1 and
GABAAR- β3. Previous studies have reported high mRNA and protein expression levels of the
β3 subunit in Jurkat cells147. Thus, we wanted to examine whether CCRF-CEM cells also
expressed this subunit. Due to the nature of the primary antibody for β3, immunocytochemistry
was not a viable option. However, using Western blot, β3 was detected as a single band at
approximately 56 kDa in both cell lines. Following normalization to GAPDH, it was
determined that Jurkat cells expressed significantly higher levels of β3 protein than CCRFCEM cells (P <0.05). Lastly, the β1 subunit was also examined in both cell lines using Western
Blot. A single band at approximately 52 kDa was detected in both cell lines. There were no
significant differences in the expression of this subunit between Jurkat and CCRF-CEM cells
(P > 0.05).
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Figure 3.6
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Figure 3.6 Protein expression of GABAAR-α1, β1, and β3 subunits in cell lines.
Immunocytochemistry and Western blot were used to detect the protein expression levels of
various GABAAR subunits in the two cell lines. A) Representative immunofluorescence
images of Jurkat and CCRF-CEM cells stained with anti-GABAAR-α1 (Cy3, Red) and DAPI
for nuclei (Blue). B) Representative Western blot images of GABAAR-α1, β1, and β3 in whole
cell lysates of Jurkat and CCRF-CEM. 100 µg of protein was loaded for GABAAR-α1 and β1
detection while 60 µg for β3 detection. Densitometry was performed using GAPDH as a
loading control. The normalized protein expression levels of GABAAR-α1, β1, and β3 were
averaged over several trials and analyzed using an unpaired student’s T-test. Data are
represented as a mean ± SEM (n=3). Each graph represents data for a different subunit.
(* indicates P < 0.05, ** indicates P < 0.01).
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3.3 Effects of GABAAR Signaling and Blockade on Functions of Jurkat and
CCFR-CEM Lines
The third aim of this thesis was to examine the effects of GABAAR activation and
blockade on the activities and functions of the two cell lines. Specifically, we examined the
effects of GABAAR signaling on cell metabolic activity, surface expression of CRTh2,
NFATc2 expression, and SOCE magnitude. Lastly, we stimulated the cells with PHA and
PMA to see whether cell activation could affect the expression levels of GABAARs. The results
of this aim are presented in this following section.

3.3.1 GABAAR blockade enhances cell metabolic activity in Jurkat cells
An MTT assay was conducted on Jurkat and CCRF-CEM cells following treatment
with GABA (100 µM) or the selective GABAAR antagonist bicuculline (100 µM) for 24 h.
GABA treatment did not affect the metabolic activity in either cell lines. On the other hand,
bicuculline significantly enhanced metabolic activity in Jurkat cells (P <0.001) while having
no effect on CCRF-CEM cells (Figure 3.7). This suggests that under normal conditions,
GABAAR signaling plays a role in regulating cell metabolic activity in Jurkat cells.
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Figure 3.7 Effects of GABA and bicuculline on cell metabolic activity.
MTT readout for Jurkat and CCRF-CEM cells treated without (control) or with GABA
(100 µM) or bicuculline (100 µM) for 24 h. The data is represented as a fold change from the
average metabolic activity of control CCRF-CEM cells. The values from each treatment were
analyzed by Two-Way ANOVA followed by a post-hoc Tukey’s test to compare the cell lines
and treatments within each cell line. The data are presented as a mean ± SEM. (*** indicates
P < 0.001)
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3.3.2 GABAAR blockade enhances CRTh2 surface expression in CCRF-CEM cells
CRTh2 is a GPCR expressed on the surface of TH2 cells. It can be activated by
prostaglandins and is critical for the survival and activity of TH2 cells. With assistance from
Meerah Vijeyakumaran in Dr. Lisa Cameron’s lab, flow cytometry was performed to analyze
the surface expression of this receptor following GABA (100 µM) or bicuculline (100 µM)
treatment for 24 h. Firstly, CCRF-CEM cells expressed significantly higher levels of CRTh2
in comparison to Jurkat cells (P <0.001; Figures 3.8A and 3.8B). GABA had no effect on
surface CRTh2 expression in either cell line while bicuculline significantly enhanced CRTh2
surface expression in the CCRF-CEM cells. This suggests that under control conditions,
GABAAR signaling mechanisms could be playing a regulatory or suppressive role in CRTh2
surface expression in the CCRF-CEM cells.
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Figure 3.8 Flow cytometric analysis of surface CRTh2 receptor expression.
A) Representative flow cytometric plots for surface CRTh2 expression in Jurkat and CCRFCEM cells. The x-axes represent the population of CRTh2-expressing cells and the y-axes
represent side scatter. B) The intensity of CRTh2 detection was normalized to that of control
CCRF-CEM cells. The average values from each treatment were analyzed by Two-Way
ANOVA followed by a Tukey’s Test to compare the cell lines and treatments within each cell
line. The data are presented as a mean ± SEM. (* indicates P < 0.05, *** indicates P < 0.001,
both relative to the control CCRF-CEM group).
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3.3.3 GABAAR blockade increases nuclear NFATc2 expression in Jurkat cells
NFAT is a key transcription factor present in the cytoplasm of resting T cells. When T
cells are activated, NFAT translocates into the nucleus to promote the transcription of genes
required for T cell functions160. We examined the nuclear expression levels of NFATc2 in
Jurkat and CCRF-CEM using immunocytochemistry and Western Blot. Interestingly, NFATc2
expression was co-localized with DAPI (nucleus marker) in all conditions (Figures 3.9A and
3.9B), suggesting that these cell lines are activated and Ca2+ signaling occurs even without any
stimulation.
Using Western blot, we found that the selective GABAAR antagonist bicuculline
significantly increased NFATc2 expression in Jurkat cells (P < 0.05) while having no effect on
CCRF-CEM cells (Figure 3.9C). GABA treatment had no effect on NFATc2 expression in
either cell line (data not shown). This suggests that under control conditions, GABAAR
signaling plays an active role in suppressing NFATc2 expression in Jurkat cells. Moreover,
CCRF-CEM cells contain higher levels of NFATc2 under control conditions. It could be
possible that we did not see an effect of bicuculline in the CCRF-CEM cells due to saturation
in the levels of NFATc2.
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Figure 3.9 Protein expression of nuclear NFATc2 in Jurkat and CCRF-CEM cells.
Expression levels of nuclear NFATc2 under control, bicuculline, and PHA/PMA conditions
were examined. A) Representative immunofluorescence images of NFATc2 (Alexa488;
Green) and DAPI (Blue) staining in Jurkat and CCRF-CEM cells under various conditions.
The top panels show an overlay of NFATc2 and DAPI while the bottom panels show NFATc2
alone. B) Western Blot of NFATc2 and GAPDH in whole cell lysates of Jurkat and CCRFCEM cells treated with or without bicuculline for 24 h. The average values from each treatment
were analyzed by Two-Way ANOVA to compare the cell lines and treatments within each cell
line. The data are presented as a mean ± SEM. (* indicates P < 0.05; ** indicates
P < 0.01, both relative to control Jurkat cells).
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3.3.4 GABAAR blockade differentially regulates SOCE in the two cell lines
Store-operated Ca2+ entry (SOCE) is a critical process in T cells following cell
activation. We proposed that GABAAR signaling affects downstream activities in the two cell
lines by modulating SOCE through its effects on membrane potential. Using Ca2+ basedfluorescence imaging in control, GABA pretreated, and bicuculline pretreated cells, the
magnitudes of SOCE following thapsigargin addition were compared. The addition of
thapsigargin alone resulted in a rise in Rhod-4AM fluorescence intensity in both cell lines.
In GABA pretreated cells, there were no significant effects on the magnitude of SOCE in either
cell line (Figures 3.10A and 3.10B). However, in cells pretreated with bicuculline, Ca2+ entry
was enhanced in Jurkat cells and reduced in CCRF-CEM cells. Interestingly, bicuculline
treatment alone also caused an enhancement in Rhod-4AM fluorescence in the Jurkat cells
(Figure 3.10C).
The traces from several trials were averaged to construct a summary plot of SOCE
responses for each cell line (Figures 3.10E and 3.10F). GABA pre-treatment had no significant
effect on TG-induced SOCE in either cell line. Bicuculline caused a significant enhancement
in Ca2+ entry in Jurkat cells starting at 8 min. In CCRF-CEM cells, bicuculline significantly
reduced Ca2+ entry starting at 12 min. These data suggest that GABAAR blockade differentially
modulates SOCE magnitude in both cell lines.
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Figure 3.10
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Figure 3.10 Effects of GABA and bicuculline pre-treatment on TG-induced Ca2+ entry.
Ca2+-based fluorescence imaging was used to examine the effects of GABA and
bicuculline pre-treatment on thapsigargin-induced Ca2+ entry in Jurkat and CCRF-CEM cells.
Representative traces of A) Rhod-4AM fluorescence in thapsigargin only (yellow) and GABA
pre-treatment (green) conditions in Jurkat cells, B) Rhod-4AM fluorescence in thapsigargin
only (yellow) and GABA pre-treatment (green) conditions in CCRF-CEM cells, C) Rhod4AM fluorescence in thapsigargin only (yellow) and bicuculline pre-treatment (orange)
conditions in Jurkat cells, and D) Rhod-4AM fluorescence in thapsigargin only (yellow) and
bicuculline (orange) pre-treatment conditions in CCRF-CEM cells.
The average Rhod-4AM fluorescence intensity at each time point was taken for several
traces under the same experimental conditions and analyzed using a Two-Way ANOVA.
E) Average Rhod-4AM fluorescence values for thapsigargin, GABA pre-treatment, and
bicuculline pre-treatment in Jurkat cells. F) Average Rhod-4AM fluorescence values for
thapsigargin, GABA pre-treatment, and bicuculline pre-treatment in CCRF-CEM cells. Data
are represented as a mean ± SEM (n=3). (*** indicates P < 0.001; **** indicates P < 0.0001).
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3.3.5 GABAAR subunit expression changes following mitogenic stimulation
Physiologically, T cells require antigen presentation at the TCR and a co-stimulus to
induce SOCE and cell activation. However, many researchers use other methods to stimulate
T cells. Phytohaemagluttinin is a lectin that can crosslink TCRs and cause receptor activation.
When used in conjunction with PMA, a PKC activator, the combination can induce strong
activation of T cells161. In this part of the project, we wanted to examine whether T cell
stimulation would affect the expression levels of GABAAR subunits. It is well known that the
activation state of T cells can affect gene expression and T cells in activated states can behave
differently than those at rest. Since this project was conducted on resting Jurkat and CCRFCEM cells, this experiment would provide information on how these cells regulate GABAAR
expression in response to stimulation. Both cell lines were stimulated with PHA
(1 µg/mL) and PMA (50 ng/mL) over a period of 24 h, 48 h, and 72 h and the protein levels of
GABAARs were then examined by western blot.
Stimulation of Jurkat cells did not result in any changes in GABAAR-β3 expression
(Figure 3.11A) throughout the time course. Stimulation of CCRF-CEM cells significantly
reduced GABAAR-β3 expression by 48 h (p <0.05), and further reduced at 72 h (Figure 3.11B;
P < 0.01). The expression levels of another subunit, GABAAR-β1 was also examined.
Stimulation of Jurkat cells did not result in any changes in GABAAR-β1 expression
(Figure 3.12A) throughout the time course. Stimulation of CCRF-CEM cells did not
significantly affect GABAAR-β1 expression either; however, there was a general upward trend
associated with stimulation (Figure 3.12B).
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Figure 3.11 Effect of PHA/PMA stimulation on GABAAR-β3 expression in the cell lines.
A) Representative Western blot of GABAAR-β3 in Jurkat cells stimulated with PHA/PMA
(1 µg/mL; 50 ng/mL) for 24 h, 48 h, or 72 h. The bands were normalized to a GAPDH loading
control and plotted in a histogram. B) Representative Western blot of GABAAR-β3 in CCRFCEM cells stimulated with PHA/PMA for 24 h, 48 h, or 72 h. The bands were normalized to a
GAPDH loading control and plotted on a histogram. The average values of β3 expression were
obtained from several trials and analyzed using a One-way ANOVA followed by a Tukey’s
Test to determine statistical significance. Data are presented as a mean ± SEM (n=4).
(* indicates P < 0.05; ** indicates P < 0.01).
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Figure 3.12 Effect of PHA/PMA stimulation on GABAAR-β1 expression in the cell lines.
A) Representative Western blot of GABAAR-β1 in Jurkat cells stimulated with PHA/PMA
(1 µg/mL; 50 ng/mL) for 24 h, 48 h, and 72 h. The bands were normalized to a GAPDH loading
control and plotted in a histogram. B) Representative Western blot of GABAAR-β1 in CCRFCEM cells stimulated with PHA/PMA for 24 h, 48 h, and 72 h. The bands were normalized to
a GAPDH loading control and plotted on a histogram. The average values of β1 expression
were obtained from several trials and analyzed using a One-way ANOVA followed by a
Tukey’s Test to determine statistical significance. Data are presented as a mean ± SEM (n=4).
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Chapter 4: Discussion

4.1 Summary of results
In the present study, we first demonstrated that the human TH cell lines Jurkat and
CCRF-CEM bear similarities to TH1 and TH2 cells, respectively, and that both cell lines express
GAD and GABAAR subunits. Next, we found that GABAAR blockade differentially affected
the metabolic activity and surface expression of CRTh2 in the cell lines. Lastly, we showed
that selective blockade of GABAARs increased intracellular Ca2+ levels and the expression of
active NFATc2 in Jurkat cells but not in CCRF-CEM cells. These results demonstrated for the
first time that GABAAR-mediated autocrine signaling differentially regulates the functions of
different TH effector cell subtypes by modulating SOCE.

4.2 Unique features of Jurkat and CCRF-CEM cells
The cell lines used for this study were the Jurkat and CCRF-CEM cells, both of which
were derived from human cancerous T lymphomas. There were two main reasons for why we
chose to work with cell lines rather than primary cells. First, the aim of this thesis was to
determine whether autocrine GABA signaling can play unique regulatory roles in different TH
cells types. Since this was a relatively novel proposal, the goal was to first establish proof of
concept for this topic. Second, we were under a strict time restraint due to the nature of the
accelerated graduate program and by using cell lines, we were able to obtain a sufficient
number of cells for experiments. In other words, we simply wanted to select two unique cell
lines to study the effects of GABAAR signaling in different TH phenotypes.
We selected the Jurkat line because it is the most widely used T cell model in the study
of TH cell signaling162 and our results showed that they contain some features of TH1 cells. The
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CCRF-CEM line was chosen following a recommendation from Dr. Lisa Cameron, who at the
time was investigating this cell line as a TH2 cell model due to high expression levels of
CRTh2. As introduced previously, CRTh2 is a GPCR that plays important roles in the
development and function of TH2 cells, and has been called the most reliable marker for
detecting TH2 cells36.
Dr. Lisa Cameron’s lab demonstrated that Jurkat and CCRF-CEM cells differed greatly
in the mRNA levels of TH1 and TH2 markers. Preliminary qPCR data showed that CCRF-CEM
cells contained significantly higher levels of mRNA for CRTh2 than Jurkat cells. Moreover,
CCRF-CEM cells also contained higher mRNA levels of GATA3 and IL-13, both of which are
markers of TH2 cells. On the other hand, Jurkat cells contained higher mRNA levels of IFN-γ,
a TH1 signature cytokine163, suggesting that they more closely resemble TH1 cells. It should
be emphasized that physiologically, the boundaries between TH1 and TH2 cells are not black
and white and additional TH subtypes exist. In the present study, we simply propose that Jurkat
cells and CCRF-CEM cells bear features of TH1 and TH2 cells, respectively. To further
determine whether they were appropriate cellular models of TH subtypes, we characterized
differences in proliferation and morphology as well as SOCE and NFATc2 levels.

4.2.1 Cell size, proliferation and metabolism
The relationship between the cell size and proliferation rate of multicellular organisms
is not well understood164. It has been proposed that there is an indirect relationship between
these two factors because cells must grow to a certain size before undergoing mitosis and cell
division165. Our analysis showed that relative to CCRF-CEM cells, Jurkat cells were larger in
size with a slower proliferation rate (Figures 3.1 and 3.2). A possible explanation for this
difference in cell size could be that the faster proliferative rate of CCRF-CEM cells led to a
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larger proportion of smaller, freshly divided cells at any given time. However, the proliferation
of cancerous lines is dependent on many other factors that we did not explore.
Cellular metabolism is required for sustaining cell growth and proliferation166. Cells
that are metabolically active convert MTT, a tetrazolium compound, into formazan by
NAD(P)H-dependent oxidoreductases, producing a purple colour. The readout of this type of
assay is in the form of a colorimetric value from which cell metabolic activity is deduced.
Although statistically insignificant, there was a trend towards a higher resting metabolic
activity in CCRF-CEM cells when compared to Jurkat cells (Figure 3.7). This would be
consistent with the higher proliferation rate observed in CCRF-CEM cells because cell
metabolic activity directly fuels mitotic activity167. Further studies need to be done to confirm
whether there are differences in resting cell metabolic activity.

4.2.2 CRAC channels and SOCE
Considering that SOCE mediated through CRAC channels is critical for gene
expression and downstream activities in TH cells, we examined the expression levels of CRAC
channel proteins in the two cell lines using a Western blot. Our results showed that both Jurkat
and CCRF-CEM cells express Orai1 and STIM1 (Figure 3.3), the key protein components of
CRAC channels168. The expression levels of Orai1 and STIM1 were high in both cell lines,
suggesting that CRAC channels are critical for the function of these cells.
It has been reported that different phenotypes of TH cells contain unique Ca2+ signaling
patterns, magnitude, and rates169. Following analysis of CRAC channel proteins, we examined
the activity of CRAC channels by using thapsigargin to pharmacologically evoke SOCE. This
compound is commonly used to induce cellular SOCE in experimental settings by blocking
SERCA pumps, which are responsible for actively transporting cytosolic Ca2+ back into the
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ER to maintain Ca2+ stores. When SERCA pumps are inhibited, intraluminal Ca2+ levels in the
ER immediately decrease and SOCE is induced without the need for physiological stimulation
of receptors.
In our analyses, the magnitude of SOCE was inferred from the fluorescence intensity
of Ca2+ indicator Rhod-4AM. Since this technique only allowed for the measurement of
relative changes in Ca2+ and not actual Ca2+ concentrations, we could not quantitatively
compare the resting/basal levels of intracellular concentration of Ca2+ between the two cell
lines. Future studies should involve using quantitative measures of intracellular Ca2+ to
compare basal levels of Ca2+ in these cells. When thapsigargin (1 uM) was applied to each cell
line, the average magnitude of change in Rhod-4AM fluorescence was significantly higher in
the Jurkat cells than in the CCRF-CEM cells (Figure 3.4C). This reflected a relatively larger
SOCE magnitude in the Jurkat cells when CRAC channels were activated.
Differences in Ca2+ signaling patterns have been observed in subsets of TH cell types.
One study using flow cytometry to observe Ca2+ levels in primary TH1 and TH2 cells following
PHA stimulation reported that TH2 cells underwent a lower level of Ca2+ flux upon
stimulation169. The authors of this paper proposed that differences in Ca2+ flux of TH1 and TH2
cells may contribute to distinct cytokine production patterns by these subsets. Another study
using Fura-2 Ca2+ indicator and thapsigargin as a stimulus found similar results170. They
proposed that the combination of a faster Ca2+ clearance mechanism and weaker Ca2+-activated
K+ currents in TH2 cells accounted for the lower Ca2+ response of TH2 cells. These data are in
line with what we found in our study, in which the CCRF-CEM (our TH2-like model) showed
a smaller magnitude of SOCE compared to the Jurkat cells. It is possible that CCRF-CEM cells
contain higher resting levels of Ca2+, thereby reducing the chemical gradient and driving force
for Ca2+ entry during SOCE.
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4.2.3 Active form of NFAT
Nuclear factor of activated T cells (NFAT) is a family of transcription factors known
to play crucial roles in regulating the immune system. NFAT is a key regulator of T cell
development, differentiation, and activation. There are five types of NFAT proteins: NFATc1,
NFATc2, NFATc3, NFATc4, and NFAT5, with NFATc1 through NFATc4 being regulated by
Ca2+ signaling160. During TCR activation, intracellular Ca2+ levels rise and activate the Ca2+
sensor protein calmodulin, which in turn activates the serine/threonine phosphatase
calcineurin. The activated calcineurin dephosphorylates serine-rich domains in the amino
terminal of NFAT proteins, resulting in conformational changes to NFAT and translocation
into the nucleus where it regulates gene expression. It is thought that different Ca2+ signaling
patterns activate different sets of NFAT proteins to modulate unique gene transcription
profiles171. We studied the activity levels of NFAT2c in the two cell lines, because NFATc2 is
critical for both TH1 and TH2 responses172.
In our experiments, we used a monoclonal antibody that detects NFATc2 in the
nucleus173. Our immunocytochemistry assays detected NFATc2 completely co-localized with
nuclear DAPI staining, further supporting that this antibody detects NFATc2 in the nucleus
(Figure 3.9A and 3.9B). Interestingly, this antibody also detected the nuclear localization of
NFATc2 in resting, non-stimulated cells, suggesting that Ca2+ signaling occurs in these cells
even under resting conditions, thereby facilitating nuclear localization of NFATc2. This would
also explain why these cells proliferate without the need for external stimulation. Using
Western blot, we found that CCRF-CEM cells expressed higher levels of NFATc2 under
control conditions (Figure 3.9C). Future studies should focus on examining other forms of
NFAT proteins. Given that NFAT activity is associated with cell proliferation, this may reflect
the difference in proliferation rate between the two cell lines.
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4.2.4 Autocrine GABA signaling system
Autocrine signaling occurs when a cell produces and secretes chemical messengers that
act upon receptors on the same cell, leading to biological changes. Almost all cells types are
under the influence of autocrine signaling mechanisms. In the case of T cells, chemokine and
purinergic receptors are expressed on the cell surface and are activated by factors secreted by
the same cells7,174. We examined whether the two TH cell lines differ in the level of autocrine
GABA signaling-related proteins. Specifically, we looked at the expression of three different
GABAAR subunits in both cell lines. These were the GABAAR-α1, β1 and β3 subunits (Figure
3.6). Jurkat cells expressed higher levels of the β3 subunit, CCRF-CEM cells expressed higher
levels of the α1 subunit, and no differences were observed in the levels of β1 expression. Our
results in the Jurkat cells were consistent with a previous study that found β3 to be the most
highly expressed GABAAR-subunit in Jurkat cells while α1 subunits were expressed at
significantly lower levels147. The same study also found drastic differences among GABAAR
subunit expression between naïve CD4+ cells isolated from rat, mice and humans. Clearly, the
expression levels of different GABAAR subunits vary quite dramatically between different cell
types and species. What dictates this unique composition of GABAAR subunits in different cell
types remains unclear. What is known, however, is that both the α- and the β-subunits are
required for GABAR activation175. GABAARs have two GABA binding sites located at the
interface between α and the β subunits126,176. Both Jurkat and CCRF-CEM cells expressed at
least one type of α subunit and one type of β subunit, suggesting that these cells contain
functional GABAARs.
Our immunocytochemistry and Western blot assays showed that both cell lines
expressed the two isoforms of GAD (GAD65/67), suggesting that these cells produce and
secrete GABA molecules (Figure 3.5). In this regard, a previous study conducted by Bhat and
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colleagues detected GABA in the culture media of naïve TH cells146. These results suggest that
both Jurkat and CCRF-CEM cells could be equipped with a constitutively active autocrine
GABA signaling system.
In summary, the results discussed thus far showed that Jurkat and CCRF-CEM cells
contain TH1-like and TH2-like properties and that both cell lines express GAD and GABAARs,
likely possessing an autocrine GABA signaling system. Therefore, they are suitable cell lines
for the study of GABAAR signaling in different TH cell types.

4.3 GABA signaling in Jurkat and CCFR-CEM Cells
In the last decade, numerous studies have established GABA as an immunomodulatory
molecule9,140. Many of them have found GABA to be immunosuppressive and protective
against autoimmune and inflammatory conditions. In the context of adaptive immunity,
autoimmunity and related inflammation are generally considered to be mediated by TH1 (and
more recently, TH17) cells and cytokines. However, there have not been many reports on how
GABA affects TH2 cells and TH2-mediated diseases. We proposed that although GABA
signaling inhibits TH1 responses, it may not inhibit all subtypes of TH cells. Instead, GABA
signaling could potentially upregulate the activity/function of certain phenotypes of TH cells.
Using Jurkat and CCRF-CEM cells, two unique TH cell lines, we tested this idea by examining
the effects of GABAAR activation and blockade on certain activities of these cells.

4.3.1 Role of GABA signaling on cell metabolism and receptor protein expression
We first assessed the effects of GABAAR signaling on cell metabolic activity and
CRTh2 surface expression in the two cell lines. As introduced previously, cell metabolic
activity reflects the activation state of cells while CRTh2 expression is essential for TH2 cell
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function. We did not observe any effects on these two attributes from the addition of GABA
itself. However, we did find that GABAAR blockade with its selective antagonist bicuculline
had unique effects in the two cell lines. Specifically, bicuculline treatment enhanced the surface
expression of the CRTh2 receptor in CCRF-CEM cells but did not affect its cell metabolic
activity (Figures 3.7 and 3.8). In Jurkat cells, bicuculline significantly enhanced cell metabolic
activity but did not affect surface expression of CRTh2. These results suggest that under resting
conditions, Jurkat cells are under the regulation of autocrine GABA signaling which restrains
cellular metabolic activity, whilst in CCRF-CEM cells, autocrine GABAAR signaling regulates
the surface expression levels of CRTh2 receptors. When GABAARs are blocked with an
antagonist, these cells are released from the regulatory effects of GABA, resulting in changes
to cellular phenotype. Taken together, these results imply that autocrine GABA signaling
distinctively regulates the function/activity of different TH cells.

4.3.2 Effects of GABA signaling on SOCE and NFAT expression
To understand the potential mechanisms by which autocrine GABAAR signaling
regulates these TH cell lines, we examined the effects of GABA and bicuculline on SOCE and
NFAT expression. Our results showed that GABA had no significant effect on SOCE or NFAT
expression in either cell line, which was consistent with what was reported in the MTT and
CRTh2 flow cytometry experiments. Excitingly, GABAAR blockade with bicuculline
significantly enhanced nuclear NFATc2 expression and SOCE magnitude in Jurkat cells. This
suggests that a constitutively active autocrine GABA signaling system restrains activation of
this cell line by limiting SOCE and NFAT expression. In CCRF-CEM cells, bicuculline did
not affect nuclear NFATc2 expression but significantly reduced SOCE magnitude. This
suggests that under resting conditions, a constitutively active autocrine GABA signaling
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system also exists in these cells to facilitate, rather than limit, SOCE. The results discussed
thus far confirm that an autocrine GABA signaling system plays unique roles in each cell lines,
and its actions are likely mediated through differential modulation of SOCE.

4.3.3 Potential mechanisms by which autocrine GABA signaling regulates SOCE
As introduced previously, SOCE is the primary route of Ca2+ influx during TH cell
activation and its magnitude is largely dependent on the electrochemical gradient of Cl- across
the cell membrane. The negative resting membrane potential of cells is the main driving force
of transmembrane Ca2+ movement. The membrane potential of a cell is primarily determined
by K+ and Cl- conductance, which is in turn determined by the electrochemical gradients of K+
and Cl- across the cell membrane. The efflux of K+ and influx of Cl- would lead to a more
negative membrane potential and hence increased Ca2+ influx. For example, in T cells, an
increase in SOCE occurs when K+ channels are activated and cause membrane
hyperpolarization177.
There have been quite a few different values and ranges reported for the resting
membrane potential of T cells. One study using flow cytometry reported a value of -70 mV in
mouse spleen cells and human T cells178. Another study examined T cells from healthy and
Ataxia Telangiectasia (AT) patients, and reported that T cells from AT patients had a RMP of
-46 ± 9 mV, while normal T cells had a potential of -63 ± 4 mV 179. A more recent study found
the membrane potential of CD3+/CD45RO- T cells to be -58 ± 3.6 mV and CD3+/CD45RO+
(memory) T cells to be -37 ± 4.1 mV180. Clearly, the membrane potential of T cells varies quite
dramatically and can be influenced by diseased states and phenotype. This dramatic variation
is likely due to differential expression of K+ and Cl- channels and/or transporters.
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GABAARs are pentameric ligand-gated Cl- channels. It is believed that the opening of
GABAARs causes Cl- efflux and hence depolarization of T cells due to high intracellular Clconcentrations (30-40 mM)181,182. The Cl- equilibrium potential of T cells has been reported to
be around -33 mV183. Therefore, activation of GABAARs in T cells results in membrane
depolarization and decreased Ca2+ entry148,152. One study reported that the intracellular Clconcentration of Jurkat cells was as high as 58 mM184, suggesting that activation of Cl- channels
such as GABAARs would lead to strong Cl- efflux and membrane depolarization in these cells.
This could largely explain the results we observed in the Jurkat cell line: an enhancement in
Ca2+ entry following GABAAR blockade, which means that GABA normally has an inhibitory
role on Ca2+ entry.
However, this mechanism does not account for our observations in the CCRF-CEM
cell lines, where we observed a reduction in Ca2+ entry when GABAARs were blocked. This
suggests that in contrast to Jurkat cells, autocrine GABAAR signaling normally facilitates Ca2+
entry in CCRF-CEM cells. Previous studies in Dr. Lisa Cameron’s lab demonstrated that the
activation of TH2 cells downregulates endogenous expression of CRTh2 through an NFATmediated pathway185. This is consistent with our data because NFAT activation requires
SOCE, and we found that GABAAR blockade reduces SOCE in CCRF-CEM cells, thereby
inhibiting NFAT signaling and releasing the inhibition to CRTh2 expression.
As simplified in Figure 4.1, we propose that Jurkat and CCRF-CEM cells possess
different membrane potentials or Cl- equilibrium potentials due to different expression/activity
levels of K+ and Cl- channels as well as transporters. Specifically, we propose that the Clequilibrium potential is below the resting membrane potential in CCRF-CEM cells. Therefore,
activation of GABAARs would result in Cl- influx, membrane hyperpolarization and enhanced
Ca2+ entry.
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Figure 4.1 Proposed mechanism of how GABAAR signaling differentially acts on Jurkat
and CCRF-CEM cells.
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4.3.4 KCC and NKCC
The Cl- equilibrium potential of a given cell is determined by the transmembrane
gradient of Cl-. The chemical gradient of Cl- in neurons of the CNS is maintained through the
actions of two Cl- transporters, NKCC and KCC, which intrude and extrude Cl-, respectively.
Immature neurons express higher levels of NKCC and contain relatively high concentrations
of Cl-, resulting in a more positive Cl- equilibrium potential186. Thus, activation of GABAARs
in immature neurons leads to Cl- efflux and membrane depolarization. During neuronal
development, the expression of KCC increases, resulting in lower intracellular Clconcentrations and a lower Cl- equilibrium potential. Activation of GABAARs in mature
neurons leads to Cl- influx and membrane hyperpolarization. Therefore, changes in the
expression of these two Cl- transporters can lead to opposite actions of GABAAR signaling112.
It is largely unknown whether this reversal in Cl- intrusion/extrusion transporter expression
also occurs in effector TH cells.
With this knowledge in mind and considering that the expression of Cl- transporters in
T cells have not been well studied, we made an effort to examine the expression of NKCC1, a
ubiquitously expressed NKCC as well as KCC3 in the two cell lines. Surprisingly, we detected
higher levels of NKCC1 in the CCRF-CEM cells than in Jurkat cells (Figure 6.2). This was
unexpected because we had proposed that Jurkat cells would contain higher levels of NKCC1
that were responsible for higher levels of intracellular Cl-. Unfortunately, we were unable to
detect KCC3 in either of the cell lines. A possible explanation of this unexpected result is that
CCRF-CEM cells express relatively higher levels of Cl- extrusion transporters (such as KCCs)
relative to Cl- intrusion transporters (such as NKCCs) or that they express less K+ channels,
resulting in a more positive resting membrane potential.
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4.4 GABAAR plasticity during TH cell activation
A few studies have demonstrated that pharmacological treatments and activation states
can modulate the expression of GABAAR subunits in T cells187,188. We used the mitogen PHA
and phorbol ester PMA to stimulate the cell lines. Stimulation of Jurkat cells with these
compounds were shown to increase IL-2 production189. We found that following stimulation
over 24 h, 48 h, and 72 h, GABAAR-β3 expression was reduced in the CCRF-CEM cells, while
GABAAR-β1 expression was trending towards an increase. PHA/PMA stimulation had no
effect on GABAAR-β1 expression in Jurkat cells (Figures 3.10 and 3.11). Further studies
would help in figuring out what regulates the expression of GABAARs in specific TH
phenotypes. Nevertheless, we found that these TH cell lines regulate GABAARs differently in
response to the same stimuli. It would be worth examining the effect of GABAergic stimulation
and blockade in activated TH cells.

4.5 Roles of GABA signaling in TH1 and TH2 diseases
The literature surrounding GABA signaling in the immune system have painted it as
an inhibitory molecule in many immune cell types. However, a vast majority of these studies
were conducted in the context of TH1/M1-mediated responses while the role of GABA in
TH2/M2 responses remain elusive. In short, we know that GABA signaling plays an inhibitory
role in the proliferation and activity of macrophages and T cells from various
species

139,140,142,148,182

. Moreover, many studies have shown GABA to be protective against

TH1/M1 mediated-diseases such as EAE, T1D, rheumatoid arthritis, and collagen-induced
arthritis139,152,190–192.
Taken together, it is clear that GABA signaling plays an anti-inflammatory role in
TH1/M1 immune responses. Given the opposing roles that TH1 and TH2 cells play in adaptive
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immunity, we propose that GABA should play either a neutral or excitatory role in TH2 cells
and responses. Although the TH1 and TH2 spectrums are not clear cut dichotomies, there is still
good evidence to suggest that they are responsible for very different adaptive immune
responses193,194. Substances that facilitate TH1 development and responses generally inhibit
TH2 development, and vice versa. The studies on GABAergic signaling in TH2 responses gives
us some insight into what GABA can do in TH2 cells.
There have not been many reports on the effects of the GABAergic system in the
context of TH2 responses such as allergic asthma. It is unclear whether GABA also plays an
inhibitory role in TH2 and M2 cells, or whether it can be protective against TH2/M2 diseases.
A study done by our lab examined the role of a GABAergic system in airway epithelial cells
and found that GABA was essential for mucus overproduction in asthma195. Moreover, this
study found that IL-13 (TH2 cytokine) administration caused an increased expression of GAD
and GABAARs in the lung epithelial cells. Another study published in 2016 found that luteolin,
a functional inhibitor of the GABAergic system, was able to suppress airway mucus
overproduction in a mouse model induced by ovalbumin196. Given the significance of TH2mediated inflammation and IL-13 production in asthma pathology, it suggests that GABAAR
signaling plays an important activating role in the TH2/M2 system.
Previous studies in our lab also found that lung macrophages are equipped with a
functional autocrine GABA signaling system, and blocking this system enhanced secretion of
the M1 cytokine TNF-α. In both RAW 264.7 cells (a murine macrophage line) and primary
lung macrophages, treatment with TH1 cytokine IFN-γ and bacterial LPS reduced GAD and
GABAAR-α2 expression. Conversely, treatment with TH2 cytokines IL-4 and IL-13 caused an
increase in GAD and α2 expression145. These findings suggested that the GABAergic system
in macrophages tend to inhibit the M1 phenotype while facilitating the M2 response. The
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results of this earlier project could be extended to our results, since the M1 phenotype is
directly associated with TH1 phenotype while M2 responses are associated with TH2 responses.

4.6 Limitations and future studies
As with any scientific investigation, there are inevitably challenges and limitations
involved, the most evident in our study was the use of cell lines rather than isolated primary
cells to infer a physiological mechanism. Cell lines are transformed cells that may not reflect
the true nature of primary TH cells. Moreover, primary TH cells contain unique cellular markers
and traits that may not be fully represented by cell lines. Future studies should involve the use
of primary T cells differentiated into TH1 and TH2 cells using in vitro techniques, followed by
using in vivo models of TH1 and TH2 disease to examine GABAergic signaling. Other TH
subtypes, most notably the TH17 and Treg cells, should also be examined.
Although it is imperative to use primary cells to confirm our results obtained from the
cell lines, further studies on these cell lines are also important in helping us gain a deeper
understanding of our current results. For example, in the Jurkat and CCRF-CEM cells, we can
examine the effects of GABA signaling on cytokine production and the expression of
transcription factors and surface marker proteins unique to TH1 and TH2 cells. We can run an
ELISA or Luminex assay on signature TH1 and TH2 cytokines following treatment with GABA
agonists and antagonists. We can also run qPCR and flow cytometry experiments to examine
TH1 and TH2 transcription factors and cell surface markers. Since the focus of this thesis was
to study the cellular physiology of GABAAR signaling in a non-CNS cell type, we did not
place as much focus on the immunological aspects of TH cells. Nonetheless, these are all
important future directions to take for this project.
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Another possible direction to take would be to use electrophysiological techniques to
assess whether our proposed mechanism is true. Patch-clamp recordings can be used to
examine the movement of Cl- during GABAAR stimulation. This would help confirm our
proposal of the mechanism by which GABA acts. One of the main techniques used in this
project was Ca2+-based fluorescence imaging. This technique is not a direct measure of
intracellular Ca2+ levels and relies on the detection of a Ca2+ based fluorescent molecule. For
this reason, we were unable to take absolute quantitative measures of intracellular Ca2+ levels.
Thapsigargin is also not an endogenous inducer of SOCE and bypasses TCR engagement and
its immediate downstream pathways. In future studies, a more physiological stimulus could be
explored and we can use other Ca2+ indicators such as Fura-2 that enable quantitative detection
of Ca2+. Lastly, the effects of GABABR activation and blockade could also be examined using
selective GABABR agonists/antagonists.

4.7 Conclusions and significance
This project demonstrated that Jurkat and CCRF-CEM cells express components of the
GABAAR signaling system and that blockade of GABAARs results in changes to cellular
phenotype and activity. These results suggest that autocrine GABAAR signaling could
differentially modulate TH subtypes depending on its effects on SOCE. We propose that
variations in membrane potential and Cl- equilibrium potential contribute to whether GABA
plays a depolarizing or hyperpolarizing role in T cells. Different phenotypes of T cells may
have different Cl- signaling mechanisms that result in distinct GABAAR regulation. GABA
may also have unique effects in different TH subtypes in the body. Further studies need to be
conducted on primary TH1 and TH2 cells, as well as in animal models of TH2 disorders.
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The results from this project have several implications in clinical settings. We have
demonstrated proof of concept that GABA signaling could indeed play unique roles in different
TH cell types. Selective modulation of this system could be beneficial in different spectrums
of adaptive immune diseases. For example, in TH1-dominant disorders, the GABAergic system
signaling could be enhanced to facilitate inhibition of TH1 cell activity. In TH2 atopic disorders,
we can selectively block GABAergic signaling to reduce the activity of TH2 cells. The role of
the mammalian GABAergic system extends far beyond the CNS, and we are just scratching
the surface of its potential as a therapeutic target.
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Appendices
Appendix A: Supplementary Figures

Figure 6.1 Protein expression and localization of STIM1 and CD3 in Jurkat cells cocultured with RAW 264.7 cells and isolated primary mixed splenocytes.
Top: Representative immunofluorescence images of Jurkat and RAW 264.7 cells stained
with anti-STIM1 (Cy3, Red) and anti-CD3 (Alexa488, Green). Bottom: Representative
immunofluorescence images of mixed splenocytes isolated from mice and stained with antiSTIM1 (Cy3, Red) and anti-CD3 (Alexa488, Green). Note that CD3 is a marker for T cells.
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Figure 6.2 Protein expression and localization of NKCC1 in Jurkat and CCRF-CEM
cells.
A) Representative immunofluorescence images of Jurkat and CCRF-CEM cells stained with
anti-NKCC1 (Cy3, Red). B) Representative Western Blot of NKCC1 in whole cell lysates of
Jurkat and CCRF-CEM cells. Note the higher expression levels of NKCC1 in the CCRFCEM cells.
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